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GENERAL INTRODUCTION 
The functions of the calcium activated cysteine proteinases, calpains, are not 
completely understood. Calpains have been linked to many cellular processes including 
signal transduction, apoptosis, cell division, and cell fusion. More specifically, in skeletal 
muscle, calpain activity has been linked with protein degradation and turnover, muscle 
growth, and also myoblast fusion during cell proliferation. Because important meat quality 
traits (meat tenderization and water-holding capacity) have been linked to postmortem 
proteolysis caused by calpain activity, the focus of much research is the role of calpains in 
postmortem muscle. 
There are many changes in muscle intracellular environment that occur early 
postmortem. One of the most pronounced changes is the pH decline from near neutral pH in 
living muscle to approximately 5.6 in meat. Another change that occurs is the increase in 
ionic strength from an approximate equivalent of 165 mMNaCl in living muscle to 
approximately equivalent to 295 mMNaCl in meat (Winger and Pope, 1980-81). An 
additional change that occurs during postmortem aging of meat is an increase in protein 
oxidation (Rowe et al., 2004a; Martinaud et al., 1997). 
The calpains are thought to be responsible for much of the postmortem proteolysis of 
myofibrillar and cytoskeletal proteins in muscle, a causative factor for an increase in 
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tenderness observed in meat during postmortem storage (Goll et al., 1992; Koohmaraie, 
1992a; Koohmaraie et al., 2002). Calpain activity is influenced by intracellular 
environmental factors, including calcium concentration, pH, ionic strength, oxidation, and 
calpastatin (the endogenous inhibitor specific for calpains). Calpains have been determined 
to have a pH optimum of approximately 7.5 (Edmunds et al., 1991; Wang and Jiang, 1991). 
A decrease in pH has been shown to decrease p- and m-calpain activity (Hwang and 
Thompson, 2001 ; Rowe et al., 2001). An increase in ionic strength also has been shown to 
decrease p- and m-calpain activity (Tan et al, 1998; Elce et al., 1997; Geesink et al., 1999; 
Geesink et al. 2000; Li et al., 2004). Additionally, oxidation has been shown to decrease p-
calpain activity (Guttmann et al., 1997; Guttmann and Johnson, 1998; Rowe et al., 2004). 
The decrease in activity is hypothesized to be due to oxidation of the active site cysteine 
residue (Mehdi, 1991). 
The endogenous inhibitor of calpains, calpastatin, is co-localized with calpains in 
cells. The regulatory mechanism of calpastatin on calpain activity is not completely 
understood. In postmortem muscle, high calpastatin activity has been shown to correspond 
to a decrease in postmortem tenderization (Koohmaraie et al., 1991; Koohmaraie et al., 1995; 
Lonergan et al., 2001). Experiments designed to determine the effects of changes in 
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environment have determined that pH does not affect calpastatin inhibition of calpains 
(Qeesink and Koohmarie, 1999; Kendall et al., 1993). Kendall et al. (1993) determined that 
an interaction of lower pH and higher ionic strength did decrease m-calpain inhibition by 
calpastatin. 
The effects of oxidation on calpastatin inhibition on p.- and m-calpain are not 
understood; however, greater postmortem calpastatin activity was observed in beef steaks 
that had been irradiated when compared to non-irradiated steaks (Rowe et al., 2004b). This 
higher calpastatin activity was attributed to a decrease in p-calpain activity caused by 
irradiation-induced oxidation. p-Calpain was inactivated by irradiation and thereby 
decreased p-calpain proteolysis of calpastatin, a substrate for calpain proteolysis as well as 
an inhibitor. 
As all of these intracellular environmental factors change in the conversion of muscle 
to meat, it is important to understand the impact each of these factors have on calpain activity 
and inhibition of calpain by calpastatin. The hypothesis of this project was that pH and ionic 
strength conditions observed in postmortem muscle, in addition to oxidation and the presence 
of calpastatin will decrease activity of |i- and m-calpain. The specific objectives designed to 
test this hypothesis include: 1) evaluation of p- and m-calpain activity and their inhibition by 
calpastatin at pH and ionic strength conditions observed during postmortem conversion of 
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muscle to meat and 2) evaluation of p- and m-calpain activity and their inhibition by 
calpastatin under oxidative conditions and 3) determine interactions of pH, ionic strength, 
and oxidation effects on p- and m-calpain activity and their inhibition by calpastatin. 
Dissertation organization 
This thesis is in the alternate style format and consists of a general introduction, 
review of literature, a paper published in Journal of Animal Science 83: 1370-1376. a paper 
submitted to Journal of Animal Science, a paper prepared for submission to Biochemical 
Journal, and a general summary. The paper represents the work conducted by the first author 
to fulfill the requirements for a degree of Doctor of Philosophy. The first paper, "Effect of 
pH and ionic strength on p- and m-calpain inhibition by calpastatin" and second paper, 
"Effect of oxidation, pH and ionic strength on calpastatin inhibition of p- and m-calpain" 
were prepared according to the Journal of Animal Science Style and Form guide and include 
an Abstract, Introduction, Materials and Methods, Results and Discussion, Implications, and 
Literature Cited. The third paper, "Formation of the p-calpain/calpastatin complex allows 
activation of p-calpain under oxidizing conditions" was prepared according to the 
Biochemical Journal Instruction to Authors guide and includes a Synopsis, Introduction, 
Experimental, Results and Discussion, and Literature Cited. 
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INTRODUCTION OF LITERATURE REVIEW 
The focus of this dissertation was to determine some of the effects intracellular 
environment has on the activity of calpains and on their inhibition by calpastatin. The pH, 
ionic strength, and oxidative conditions are known to change during cellular metabolism, 
particularly in postmortem muscle cells. The hypothesis was that as intracellular 
environmental conditions change, the activity of p-calpain, m-calpain, and inhibition of 
calpains by calpastatin are affected. Each of the following topics addresses calpains and 
calpastatin, their mechanisms of action, and factors affecting their action. 
I. Calpains 
II. Classical calpain structure 
III. Activation of calpain 
IV. Autolysis of calpain 
V. Physiological role of calpains 
VI. Calpastatin 
VII. Binding of calpastatin to calpain 
VIII. Meat Quality 
IX. Meat Tenderness 
X. Calpain and Calpastatin involvement in Postmortem Tissue 
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XI. Oxidation in postmortem muscle 
XII. Protein oxidation 
XIII. Summary 
Calpains 
Calpains are a family of enzymes generally characterized as calcium-dependent 
cysteine proteinases with catalytic domain that resembles papain's. Two subclassifications 
of calpains have been suggested (Sorimachi et al., 1997). These include 'classical' or 
'conventional' forms, which include p-calpain and m-calpain. These classical forms are 
denoted as typical calpains as they are depend on calcium to be active, contain the 
calmodulin-like calcium binding domain, and they also have a papain-like catalytic domain. 
Currently, knowledge of the calpains applies predominantly to the typical calpains, p- and m-
calpain, and their naturally occurring inhibitor, calpastatin (Goll et al., 1999). 
More recently, twelve other forms of calpain, have been identified (Goll et al., 2003), 
and are often considered 'atypical', as their structures deviate from the classical structure. 
Five of the atypical calpains have been identified as tissue specific. The atypical forms are 
reasoned to be involved in the many of the pathological conditions linked to calpain activity 
as discussed below. 
The first tissue specific calpain discovered was the skeletal muscle specific calpain 3, 
or p94, (Sorimachi et al., 1989). Although the mRNA for p94 has been found, the protein 
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cannot be isolated, as it autolyzes very rapidly. Yeast two-hybrid analysis determined that 
p94 binds the myofibril in muscle, and more specifically to titin (Kinbara et al., 1997; 
Sorimachi et al., 1995). Calpain 3 is thought to be involved in muscle differentiation by 
interacting with the MyoD family (Weintraub, 1993). Various mutations in the calpain 3 
gene has been identified in patients with limb-girdle muscular dystrophy (Ono et al., 1998) 
which is thought to results in a loss of proteolytic activity and loss of binding to titin. Genes 
for other atypical calpains have been determined, including smooth muscle specific calpain 8 
(Sorimachi et al., 1993), calpain 6 in placental tissues, calpain 11 in testis, and calpain 12 in 
the skin. 
Another atypical calpain, calpain 10, has received much attention as it has been 
linked to insulin resistance and type 2 diabetes (Horikawa et al., 2000). Calpain 10 is 
expressed in many tissues and it considered ubiquitous. The assumed structure of calpain 10 
(based on domain architecture) determined that domains I-III are similar to p- and m-calpain, 
(described in detail later). However, calpain 10 does not contain the EF-hand structures 
identified with the classical calpains, but in fact has a T domain at the COOH-terminal that 
does not have predicted calcium binding sites (Horikawa et al, 2000; Ma et al., 2001). 
Calpains are located within the cell (Kumamoto et al., 1992). Prior to calcium 
binding, both subunits of calpain are homogenously distributed in the cytoplasm (Gil-Parrado 
et al., 2003), with slight prevalence around the nuclear region. After activation, migration of 
calpains toward the cell membrane has been observed (Gil-Parrado et al., 2003) by 
identifying ionomycin activated p-calpain at the cell membrane. This movement toward the 
cell membrane has been hypothesized to be involved in lowering the calcium requirement for 
calpain activation and autolysis (Mellgren, 1987 and Suzuki et al., 1987) or regulation of 
calpain activation through binding of phospholipids (Saido et al, 1992; Coolican and 
Hathaway, 1986) or proteins (Inomata and Kawashima, 1995; Inomata et al., 1990). In 
skeletal muscle, |> and m-calpain have been found in greatest abundance associated with the 
myofibrils at the Z-disk (Goll et al., 1992; Spencer and Tidball, 1992). 
Classical calpain structure 
(j- and m-Calpain are heterodimers, with a large subunit of approximately 80 kDa and 
a smaller subunit of 28 kDa. The terms of p-calpain and m-calpain refer to differing Ca2+ 
requirement for their activation (Cong et al., 1989). jn-Calpain requires 3-50 |iM calcium ion 
concentration for half maximal rate of proteolytic activity (Edmunds et al., 1991) and m-
calpain requires 400-800 (J.M calcium ion concentration for half maximal rate of activity 
(Goll, 1991). Because intracellular calcium concentrations fluctuate normally at 
submicromolar levels, p-calpain is more likely to be functional in cells under physiological 
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The 80-kDa subunits of p.- and m-calpain have 55-65% homology (Suzuki, 1991) and 
are the products of two separate genes (Ohno et al., 1990). The 28 kDa subunits of (i-and m-
calpain are identical and encoded by the same gene (Ohno et al., 1986). Recently, Hosfield 
at al. (1999) and Strobl et al. (2000) revealed the crystal structure of calcium-free m-calpain. 
The 80 kDa subunit of m-calpain was revealed to contain six domains (Strobl at al. 2000). |i-
Calpain has not been crystallized, so it is not known if the large subunit contains these six 
domains (Goll et al., 2003). Two domains, Domain I or the NHi-terminal domain and the 
linker domain identified in m-calpain, are not typical domains, as they contain only 18 and 
17 amino acid residues respectively. Discussion of domain structure of both calpains will be 
based on the crystal structure of m-calpain (domain structure shown below as modified from 
Goll et al., 2003). 
I lia lib m Linker jy 
80 kDa N 1 1 1 
H N 
28 kDa N 
C 
C 
V VI 
Domain I is known as the anchor domain and is proposed to connect with domain V 
of the small subunit (Strobl et al., 2000; Reverter et al., 2001). Domain II is where the active 
site is located. The cysteine, histidine, and asparagine residues make up the catalytic triad 
common to cysteine proteases. Domain II is divided into two functional subdomains, lia and 
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lib. Subdomains Ha and lib are placed opposite of each other to form a cleft where 
substrates bind. In the inactive form of calpain, this cleft is open preventing proper 
alignment the active site needed for activation (Hosfield et al., 1999). Domain Ha is where 
the active site cysteine residue is located (Cys105 for m-calpain and Cys115 for ^-calpain). 
Domain lib contains the two other residues (His262 and Asn286 for m-calpain and His272 and 
Asn296 for ^-calpain) of the catalytic triad required for activation. The crystal structure of the 
Ca2+-bound DII domain specifies binding of Ca2+ ions that bridge the subdomains to form the 
catalytically competent active site (Moldoveanu et al., 2002). 
Domain III has been hypothesized to aid in regulation of calpain activity via 
electrostatic interactions (Strobl et al., 2000) and Ca2+-dependent binding of phospholipids 
(Tompa et al., 2001). Strobl et al. (2000) hypothesized that calcium binding to the negatively 
charged acidic loop in domain III could allow for a conformational shift of the catalytic site 
with domain Ha and lib to moving closer towards each other, aligning the active site in 
proper conformation allowing catalytic activity to occur. Alexa et al. (2004) tested this 
hypothesis and determined that calpains with mutations of the acidic loop that Domain III 
can bind 3 Ca2+ ions in the absence of liposomes, and two Ca2+ in the presence of liposomes. 
Gil-Parrado et al. (2003) determined that when a calpain fragment contained only domain III; 
it migrated to membranes upon exposure with ionomycin, suggesting a role for Dili in 
membrane targeting. 
Domain IV is called the calmodulin like domain as it contains E-F hand Ca2+-binding 
sites. The crystal structure of m-calpain (Strobl et al., 2000) determined that there are in fact 
five EF-hand structures. The first three N-terminal EF-hand structures bind Ca2+ (Blanchard 
et al., 1997). The fifth EF-hand structure is involved with dimerization of the two subunits 
(Strobl et al., 2000). Dutt et al. (2000) determined that the calcium binding mechanism of the 
EF-hand structures occurred based on order of importance for activation and determined that 
the third EF-hand structure from the NHz-end of domain IV had the greatest affinity for 
calcium. 
A linker region determined by the crystal structure of m-calpain connects domains III 
and IV may play a role in directing the conformational changes occurring in domains IV and 
VI that are essential for activation of calpains (Alexa et al., 2004). 
The small subunits of |> and m-calpain are identical as they are encoded by the same 
gene (Ohno et al., 1986) and contain domains V and VI. Domain V, the NHa-terminal 
region, is rich in glycine and often considered the hydrophobic domain. It has been 
hypothesized that domain V binds phospholipids (Imajoh et al., 1986), but Goll et al. (2003) 
suggested that domain V may play a larger role in interactions with other molecules or 
structures as its hydrophobicity is not extreme. 
Domain VI is the COOH-terminal portion of the small subunit. It is very similar to 
domain IV as it contains five EF-hand structures for binding of calcium and is thereby also 
considered a calmodulin-like domain. The X-ray crystallography of m-calpain also 
determined that a fifth E-F hand was located in domain VI, interacting with the fifth EF-hand 
structure in domain IV in the large subunit (Blanchard et al., 1997). 
In addition to the calcium binding sites in domains IV and VI, the crystal structure of 
m-calpain revealed a calcium binding site located in domain III (Strobl et al. 2000) and two 
calcium binding sites have been identified in domains I and II (Moldoveanu et al., 2002). 
The "extra" binding sites probably have implications in the calcium mediated activation of 
calpains. 
Activation of calpain 
Both the large and small subunits play an important role in the activation and function 
of calpains. Because most of the information about structural changes occurring during 
calpain activation have been deduced from the m-calpain crystal structure, most of the 
following discussion relates to m-calpain. Mainly, inactive m-calpain is the result of the 
large cleft between domains Ha and lib, causing a misalignment of the three amino acids 
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required for the catalytic triad (Strobl et al., 2002). The binding of calcium at the EF-hands 
in Domains IV and VI causes a small conformational change (Blanchard et al., 1997; Lin et 
al., 1997), leading to loss of contact between the N-terminal domain in the large subunit and 
domain VI of the small subunit and also between domains IV and VI. The initial phase of 
activation requires high Ca2+ concentration, which decreases after activation (Goll et al., 
1992) and autolysis has occurred. Moldoveanu et al. (2002) determined that Ca2+ binding at 
two sites in an p-calpain protease core containing active site domains I and II causes 
conformational changes that bring the active site residues into a conformation that is fully 
active. Strobl et al. (2000) hypothesized that calcium binding to the negatively charged loop 
on domain III could release subdomain lib to move closer to subdomain lia for alignment of 
the active site. 
As the conformational change due to binding of calcium to the EF-hand regions of 
domains IV and VI is quite small, it has been discussed whether this small change can have 
any effect in resolving the active site misalignment for calpain activation. Alexa et al. (2004) 
hypothesized that the linker region, or transducer region, could possibly act as a "stiff rope" 
that can help bring the conformational changes occurring in domain IV to domain II for 
activation. They suggested that the linker can act as an entropie spring mechanism, where it 
loses its upper region electrostatic interaction with domain IV when Ca2+ binds, causing the 
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molecule to shift to a more compact conformation. Further diagnosis of these hypotheses 
(Bozoky et al., 2005) determined that the transducer must break its interaction with domain 
IV, which could help to explain the large effect of the very small conformational changes 
occurring in domains IV and VI during Ca2+ binding. 
Autolysis of calpain 
Autolysis of m-calpain was noted by Suzuki et al. (1981). During autolysis, the 80 
kDa subunit autolyzes to a 79 kDa and further to a 78 kDa peptide in the presence of 
calcium. Autolysis of |i-calpain was determined later (Dayton 1982) where the 80 kDa 
subunit autolyzes to a 78 kDa and further to a 76 kDa subunit. The small subunit autolyzes 
from the 28 kDa subunit to an 18 kDa subunit in both \x- and m-calpain. 
Autolysis has been determined to occur in a series of steps. Autolysis of jj.-calpain 
occurs with the removal of 14 amino acids at the NHa-terminal to produce the 78 kDa 
fragment, followed by removal of another 12 amino acids to produce the 76 kDa fragment 
(Zimmerman and Schlaepfer, 1991). Autolysis of m-calpain occurs by the removal of 9 
amino acids from the NHa-terminal to produce the 79 kDa fragment, followed by the removal 
of 10 additional amino acids to produce the 78 kDa fragment (Brown and Crawford, 1993). 
The small subunit in both p- and m-calpain also autolyzes from the NHa-terminal region on 
the 28 kDa subunit to a 26 kDa fragment with the removal of 26 amino acids, which is 
followed by removal of 37 more amino acids to produce a 22 kDa fragment, and finally 28 
more amino acids are removed to produce the 18 kDa fragment (McClelland et al., 1989). 
Autolysis of the 28 kDa subunit in m-calpain occurs more rapidly than the 80 kDa subunit, 
however in (x-calpain, autolysis of the large subunit occurs at the same or faster rate than the 
small subunit (Zimmerman and Schlaepfer, 1991). 
Autolysis lowers the Ca2+ concentration required for half maximal activity of p-
calpain from 3-50 pM to 0.5-2.0 |_iM and m-calpain from 400-800 |_iM to 50-150 |iM (Goll et 
al., 1995). fi- and m-Calpains require greater calcium for autolysis to occur than is required 
to activation after autolysis. The reason for this difference in calcium concentrations is still 
unclear. Regardless, the calcium concentration in living cells ranges from 50-300 nM 
(Maravell et al., 2000), which is not high enough to activate p.- and m-calpains. 
As stated earlier, domain III of [> and m-calpain may be a location for phospholipid 
binding, explaining observations that ^-calpain migrates towards the cell membrane after 
exposure to calcium. Phosphatidylinositol has been shown to lower the calcium 
concentration required to initiate autolysis of ^-calpain (Cong et al., 1993; Saido et al., 1992) 
and m-calpain (Coolican and Hathaway, 1986). However, the calcium concentration 
required to activate these calpains exposed to phospholipids is still higher that calcium 
concentration measured in living cells. 
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Autolysis has often been used as an indicator of calpain activation (Baki et al., 1996). 
Baki et al. (1996) observed that microtubule associated protein 2 (MAP2) degradation 
occurred after autolysis of ^-calpain. They surmised that these results indicated autolysis 
must occur for proteolytic action of p-calpain to be activated. However, Molinari et al. 
(1994) determined that p-calpain did not require autolysis to cleave Ca2+-ATPase and the 
calpain substrates erythrocyte Band 3 and Band 4.2. Migration of calpains to the cell 
membrane allowed for a reversible activation of calpain without the occurrence of autolysis 
(Molinari et al., 1994). These two ideas of calpain proteolytic activation have been the basis 
of much discussion. In a review by Goll et al. (2003), it was determined that with the current 
knowledge, autolysis can be used as an indicator of activation, but lack of autolysis does not 
guarantee that calpains have not been active. Clearly, autolysis of |i- and m-calpain will be 
an area of much research in the future as it may play an important role in calpain activation. 
Physiological role of calpains 
The physiological roles of calpains in tissues are not completely understood. 
However, the detection of |a- and m-calpain in most tissues suggest that they contribute to 
cellular processes that include signal transduction, apoptosis, cell division and cell fusion 
(Sorimachi et al., 1997; Carafoli and Molinari, 1998; Ono et al., 1998; Hosfield et al., 2001). 
Studies in transgenic mice indicate that the calpain small subunit is necessary for survival of 
embryos (Arthur et al., 2000). A knockout of the 80 kDa subunit of [i-calpain was not 
embryonically lethal (Azam et al. 2001) and mice were viable and fertile. m-Calpain was 
present in these mice and appeared to compensate for the lack of ^-calpain, which may 
indicate that substrates of (i- and m-calpain are similar. 
The calpain system has also been implicated in several pathological conditions such 
as limb girdle muscular dystrophy type 2A which, as discussed previously, is caused by lack 
of calpain 3 activity. The loss of activity is attributed to fifteen nonsense, splice site, 
frameshift, or missense mutations in the calpain 3 gene (Richard et al., 1995). Duchenne and 
Beckers muscular dystrophy are also linked to calpain action, but are due to an increase in 
intracellular calcium due to a loss of calcium homeostasis, which allows calpain degradation 
of dystrophin (Tidball and Spencer, 2000). Type 2 diabetes is associated with a 
polymorphism in the calpain 10 gene expressed ubiquitously in tissues (Horiwaka et al., 
2000) which may affect insulin action, secretion, or production. Paul et al. (2003) 
determined that inhibition of calpain 10 activity prevented the translocation of the insulin-
response glucose transporter 4 (GLUT 4) to the plasma membrane. It was proposed that 
calpain 10 activity is required for actin reorganization responsible for the movement of 
GLUT 4, thus preventing glucose uptake into the cell. Loss of calcium homeostasis also 
occurs in cardiac and cerebral ischemia, which triggers uncontrolled m- and g-calpain 
activity causing tissue damage associated with apoptosis and necrosis (Blomgren et al., 
2001). Cataract formation is due to activation of m-calpain upon a calcium influx into the 
lens (Shearer et al., 1999) where a-crystallin and (3-crystallin are degraded and their 
degradation products accumulate to form the cataract. Studies have shown increased m-
calpain activity in the brain of patients with Alzheimer's disease (Tsuji et al., 1998). (x-
Calpain autolytic fragments are also present at higher than normal levels in brain tissue (Saito 
et al., 1993). 
m-Calpain was first purified in porcine skeletal muscle (Dayton et al., 1976). 
Additionally, many of the early reports on calpain were from studies in rabbit skeletal muscle 
(Azanza et al., 1979) or chicken skeletal muscle (Ishiura et al., 1978). Both |i- and m-calpain 
cleave myofibrillar and cytoskeletal proteins at a limited number of sites, resulting in large 
polypeptide fragments (Goll et al. 1999). Calpains do not target all cytoskeletal proteins, but 
fx- and m-calpain appear to have the similar substrate specificity. Calpain has been shown to 
degrade desmin (O'Shea et al., 1979), troponin T (Ho et al., 1994), titin (Suzuki et al., 1996), 
nebulin (Huff-Lonergan et al., 1996), talin (Hemmings et al., 1996) and vinculin (Evans et 
al., 1984). However, calpain does not degrade the main myofibrillar proteins, actin (Goll et 
al., 1991) and myosin (Pemrick and Grebanau, 1984), although recent evidence suggests the 
^-calpain could cleave sites on actin, myosin heavy chain, and myosin light chain I 
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(Lametsch et al., 2004). Lametsch et al. (2004) attributed this discrepancy to |!-calpain 
cleaving only small peptides off of intact actin and myosin, which is not detectable by SDS-
PAGE. However, by using 2-D gel electrophoresis and matrix-assisted laser desorption/ 
ionization time-of-flight mass spectrometry (MALDI-TOF MS), actin, myosin heavy chain, 
and myosin light chain fragments were identified in p-calpain digested myofibrils that were 
no present in the control myofibrils (Lametsch et al., 2004). 
One of main functions of calpains in skeletal muscle is thought to be involvement in 
protein turnover (Dayton et al., 1976). Myofibrillar protein breakdown into myofilaments 
occurs first, with subsequent breakdown to polypeptides and ultimately free amino acids. 
Goll et al. (1992) hypothesized that calpains are the proteinases involved in the specific 
cleavages required to release the myofilaments. 
Another role of calpains in skeletal muscle is thought to be m-calpain involvement in 
myoblast fusion through degradation of cytoskeletal/plasma membrane attachments (Dedieu 
et al., 2004). When calpastatin was microinjected into C2C12 cells (Temm-Grove et al., 
1999), fusion of the myoblasts was prevented. Western blot analysis indicated that only m-
calpain was detectable in the cells before fusion, indicating that m-calpain is most likely the 
calpain involved in myoblast fusion. Dedieu et al. (2004) evaluated migratory ability of 
myoblasts with a four-fold increase in calpastatin and a two-fold decreased calpain activity. 
It was observed that fusion of these cells into myotubes was completely prevented. 
Morphological differences were observed, where in the cells overexpressing calpastatin 
presented a round morphology and the control cells had a spreading morphology. 
Differences were not observed in concentrations of known calpain substrates such as desmin, 
talin, and vinculin; however, increased levels of myristoylated alanine-rich C kinase substrate 
(MARCKS) were observed in cells overexpressing calpastatin. Myoblasts with MARCKS 
overexpression show decreased migratory capacity. MARCKS is a known actin binding 
protein and its degradation may be important in the cytoskeletal reorganization that occurs 
during myoblast fusion (Dedieu et al., 2004). 
Schollmeyer (1988) monitored m-calpain localization throughout the cell cycle in 
PtKi cells. m-Calpain was associated with the chromosomes during anaphase. m-Calpain 
was observed at a bilateral location at the cell membrane and associated with the cytoplasmic 
bridge during telophase. At interphase, m-calpain was localized primarily at the cell 
membrane, indicating relocalization of m-calpain during the cell cycle. A second experiment 
was conducted in this study where m-calpain labeled with rhodamine siothiocyanate was 
injected near the nucleus of a cell in interphase. This injection of m-calpain increased the 
rate that the cell moved from interphase to metaphase. Injection of m-calpain into the cells at 
late metaphase also increased the rate of transition from metaphase to anaphase. It was 
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concluded that m-calpain could cause hydrolysis of microtubule-associated proteins, 
resulting in disassembly of microtubules of the mitotic spindle, helping to progress cells 
through the cell cycle. A recent study (Raynaud et al., 2004) evaluated calpain activity in 
myoblasts during the cell cycle and determined that cell cycle progression from Go to Gi 
seems to be dependent on m-calpain activity. m-Calpain was localized in the nuclei during 
the Gi phase, but if cells were treated with calpain specific inhibitor MDL 28170, m-calpain 
did not accumulate in the nucleus and Go cell cycle withdrawal did not occur. The role of 
calpains in muscle growth and myoblast proliferation and fusion is only starting to be 
understood. It is clear that calpains, particularly m-calpain, is a necessary for normal muscle 
development. 
Calpastatin 
An inhibitor of calpain activity was discovered in the purification of m-calpain 
(Dayton et al, 1976). Murachi (1989) named this inhibitor calpastatin. Calpastatin is 
ubiquitously expressed in cells (Ouali and Talmant, 1990) and is specific for |i- and m-
calpain inhibition. Since the primary role of calpastatin is regulation of calpain, it follows 
that calpastatin is a regulator of calpain mediated processes. 
Calpastatin is considered an IUP (Intrinsically Unstructured Protein) (Konno et al., 
1997). IUPs have functional importance often related to regulatory roles in key cellular 
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processes (Tompa, 2002). These proteins are known for their lack of folded structure but 
highly flexible random-coil-like conformation (Wright and Dyson, 1999). The random coil 
formation of calpastatin was determined by circular dichroism and magnetic resonance 
(Konno et al., 1997) where no secondary or tertiary structure for calpastatin was apparent. 
Like most IUP's, calpastatin is a very heat stable protein (Okitani et al., 1976) and is resistant 
of denaturing agents such as urea, SDS, 6 M guanidinium hydrochloride and trichloroacetic 
acid (Geesink and Koohmaraie, 1999; Otsaka and Goll, 1987). 
Complementary DNAs encoding calpastatin have been cloned in human, monkey, 
mouse, rat, pig, bovine, and rabbit (As reviewed by Goll et al., 2003). The amino acid 
sequences of calpastatin consist of 713 residues for pig heart calpastatin (Takano et al., 
1988), 706 residues for beef skeletal muscle (Killefer and Koohmaraie, 1994), and 718 
residues for rabbit lung or liver (Emori et al, 1987). The structure of calpastatin (shown 
below) consists of four repeating inhibitory domains (I, II, III, and IV) of approximately 140 
amino acids each, and an L-domain at the N-terminal (Emori at al., 1987; Takano et al., 
1988). The inhibitory domains are approximately 22.5 to 36.0 % percent identical (Takano 
et al., 1988). 
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Purified calpastatin has an isoelectric point of 4.55 (Takano and Murachi, 1982). 
Interestingly, the isoelectric point of each inhibitory domain is similar (ranging from 4.26 to 
4.90), but the isoelectric point of the L-domain is 10.27 (Lee et al., 1992). Each single 
inhibitory domain can inhibit the activity of n- or m-calpain, so theoretically, one calpastatin 
molecule can inhibit four calpain molecules (Emori et al., 1988, Maki et al., 1988). Domain I 
is more effective at inhibiting calpain than IV, which is greater than II, which is greater than 
III (Kawasaki et al., 1993) which is attributed to the location each domain on the calpastatin 
molecule. Within each inhibitory domain are three homologous subdomains A, B, and C. 
Subdomain B has been shown to be essential for inhibitory activity to occur (Kawasaki et al., 
1993; Maki et al., 1988) and contains a conserved sequence, LGXK(R)D(E)XYIPPXYRLL, 
whereas removal of subdomains A and C does not prevent inhibition of calpains. The L-
domain has no inhibitory activity (Takano et al., 1999) although phosphorylation by protein 
kinase C and protein kinase A of a serine site in the L-domain region increases the Ca2+ 
concentration required for binding to calpains, which decreases inhibitory activity on 
calpains (Averna et al., 1999). More recently, Avema et al. (2001) determined that 
phosphorylation of calpastatin was involved in intracellular localization of calpastatin, where 
dephosphorylated calpastatin was the active form and distributed throughout the cell. Once 
cAMP-dependent phosphorylation had occurred, calpastatin aggregated and relocalized 
towards the nucleus. The L-domain region has also been reported to be involved with 
binding of calpastatin to cell membranes (Mellgren et al., 1989), however, observed levels of 
calpastatin bound to the sarcolemma in cardiac muscle is less than 2 %. Lee at al. (1992) 
hypothesized that the basic residues found in the L-domain explain binding of calpastatin to 
membranes, and may play a role in stabilization of the calpastatin molecule. 
The molecular weight of calpastatin has been reported to range from 34 to 300 kDa. 
This variation in molecular weights is due to many different properties of calpastatin. 
Overestimation of calpastatin molecular weight (> 200 kDa) occurs when subjected to size 
exclusion chromatography due to calpastatin being a random coil (Konno et al., 1997; 
Shannon and Goll, 1985). Calpastatin migration on SDS-PAGE gels also overestimates 
molecular weight by 50-60 % (Maki et al., 1991). These high molecular weight estimations 
may be explained by the amino acid composition as calpastatin contains a large number of 
basic residues, which slow down gel migration. Another explanation of the variation in 
molecular weight is because, although calpastatin is a single gene product, studies have 
shown that different promoters and alternative splicing mechanisms cause a number of 
different calpastatin isoforms (Imajoh et al., 1988; Cong et al., 1998). The mouse calpastatin 
gene sequence shows that the calpastatin gene consists of 34 exons, of which five are 
upstream from exon 2. Exon 2 encodes the L-domain NHz-terminal region (Takano et al., 
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2000) for what is called "protypical" calpastatin (Goll et al., 2003). Takano et al. (2000) 
classified four types of mammalian calpastatins with distinct N-terminal sequences based on 
these upstream exons. Type I calpastatin is based from mouse myoblasts and started at exon 
lxa and has an extended region on the NH^-terminal and predicts an 85 kDa polypeptide. 
Type II calpastatin is based from bovine heart and is started at exon lxb and contains an 
extended region of the NHz-terminal called the XL domain and predicts an 84-kDa 
polypeptide. Type III calpastatin starts at exon lu and encodes the prototypical calpastatin. 
It is expressed in many tissues including all rabbit tissues tested, pig heart, bovine skeletal 
muscle, rat liver and brain and predicts a polypeptide with a range from 72-78 kDa. Type IV 
calpastatin starts at exon 14t, located downstream from exon 2, and determined to be initiated 
in domain II, after subdomain A and it is expressed in human testis and predicts a 35 kDa 
polypeptide. Takano et al. (2000) hypothesized the differences in transcribed calpastatins is 
due to different promoters specific for these exons. More recently, Raynaud et al. (2005) 
determined specific promoters (individually located upstream of exons lxa, lxb, lu, and 14t) 
were functional which further validates the conclusion of Takano et al. (2000). 
Calpastatin is susceptible to proteolytic degradation which also contributes to the 
variation in the molecular weight (Mellgren and Carr, 1983; Mellgren et al., 1986; Otsaka 
and Goll, 1987). Calpastatin not only inhibits calpain, but is also a substrate of calpain (Goll 
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et al., 1983). Calpastatin is cleaved by calpain in the interdomain regions which in turn 
generates inhibitory peptides and can then inhibit more than one molecule of calpain. It has 
been demonstrated that degradation of calpastatin by calpain does not result in the loss of 
calpastatin's ability to inhibit the calpains (Goll et al., 1983; Mellgren et al., 1986; Mellgren 
and Carr, 1983). However, Doumit and Koohmaraie (1999) disagreed with this hypothesis 
and showed that degradation of calpastatin by ^-calpain did reduce inhibitory activity. The 
different results of this study were attributed to the fact that previous studies were based 
qualitative assays, not quantitative. Doumit and Koohmariae measured a lower calpastatin 
activity after incubation with ^-calpain, whereas previous studies did not measure actual 
calpastatin activity. It is possible that the extent of calpastatin proteolysis indicates whether 
or not inhibitory activity is maintained. 
Binding of Calpastatin to Calpains 
The exact mechanism of calpastatin in binding to and inhibiting g-calpain and m-
calpain is not defined (Goll et al., 2003). Calpastatin is co-localized intracellular^ with 
calpains (Kumamoto et al., 1992). Calcium is required for binding of calpastatin to calpains 
(Cottin et al., 1981; Otsuka and Goll, 1987) and binding is reversible upon removal of 
calcium. The Ca2+ concentration required for binding of calpastatin to p- and m-calpain is 
lower than the Ca2+ concentration required for calpain proteolytic activity at half-maximal 
rate. This indicates that, if present, calpastatin will bind and inhibit calpain before it can 
become proteolytically active (Kapprell and Goll, 1989). Both p.- and m-calpain and the 
autolyzed form of m-calpain all require lower Ca2+ concentrations for binding calpastatin, but 
the Ca2+ requirement for autolyzed (i-calpain is approximately the same as the Ca2+ 
requirement for activation of autolyzed ^-calpain (Kapprell and Goll, 1989). Calpastatin 
cannot inhibit the initial autolysis step of the 80 kDa subunit of ^-calpain, but it can further 
inhibit calpain autolysis from 78 kDa to 76 kDa (Johnson and Guttman, 1997; Zimmerman 
and Schlaepfer, 1991). 
Calpastatin binds to three sites on the calpain molecule: subdomain A of calpastatin 
binds to domain IV in calpain, subdomain C of calpastatin binds to domain VI in calpain, 
then subdomain B of calpastatin binds to an area near the active site. Kinetic assays indicate 
that calpastatin is a competitive inhibitor of calpain (Croall and McGrody, 1994). However, 
evidence indicates that calpastatin does not bind at the active site of p- or m-calpain 
(Nishimura and Goll, 1991, Croall and McGrody, 1994), but rather near the active site in a 
way that blocks access of substrates as hypothesized by Todd et al. (2003). As previously 
discussed, domain III of m-calpain contains an electrostatic switch (Strobl et al., 2000) and 
calcium binding sites (Alexa et al., 2003) that may play a role in the alignment of the calpain 
active site. Croall and McGrody (1994) determined that a calpastatin binding site is likely at 
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a highly conserved region in domain III of the calpain large subunit. Binding of calpastatin 
to this area in domain III is a possible mechanism behind calpain inhibition as calpastatin 
may prevent calcium binding from occurring at domain III of calpains, thus preventing the 
alignment of the active site required for activation. 
Subdomains A and C appear to prevent calpain from associating with membranes 
when bound to calpain at domains IV and VI (Kawasaki et al., 1993). The interaction of 
subdomains A and C with calpains is calcium dependent. Tompa et al. (2002) observed an 
increase in p-calpain and m-calpain activity upon interaction with subdomains A and C in the 
absence of subdomain B. They suggested a role for calpastatin fragments in activation of 
calpains in vivo and hypothesized the subdomains A and C of calpastatin decrease the 
calcium requirement of calpains for activation and help to shift the conformation of calpains 
into the active form. 
Localization of calpains and calpastatin in the cell may also explain activation of 
calpains in the presence of calpastatin. Gil-Parrado et al. (2003) observed that in LCLC 103 
H cells both calpain and calpastatin were distributed in the cytoplasm, and calpastatin was 
also observed in the nucleus. When calpain was redistributed in the cell towards the 
membrane through activation with ionomycin, the nuclear localization of calpastatin was 
unchanged. 
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Meat Quality 
Meat quality is a generic term used to describe properties and perception of meat. It 
includes composition and conformation, the eating quality such as juiciness, tenderness, 
flavor, and aroma, health issues associated with microbial contamination and other diseases, 
and also includes animal welfare and environment. All these attributes are described as 
important traits by the consumer (Boleman et al., 1997). The main source of consumer 
complaint with meat quality is the variability in eating quality, especially tenderness (Bindon 
and Jones, 2001). 
The National Beef Tenderness Survey (Morgan et al., 1991) determined an 
unacceptable level of variation of tenderness in retail beef cuts. Boleman et al. (1997) 
determined that consumers can distinguish differences in tenderness and are willing to pay 
premiums for improved tenderness. The current system, U.S. Quality grade, is set up so that 
beef subprimals are priced according to their expected palatability. However, there has been 
much debate on whether or not quality grade can distinguish differences in palatability, 
particularly tenderness differences. Methods to predict tenderness quickly in a plant setting 
have not been successful, particularly in sorting out tender cuts in US Select carcasses. 
Shackelford et al. (2005) have recently evaluated the effectiveness of visible and near-
infrared spectroscopy in predicting tenderness of US Select carcasses, and determined that 
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this technology was successful in sorting tender cuts from tough cuts based on shear force 
values and sensory panel evaluations and could be a step towards guaranteeing tenderness in 
retail sales. 
Tenderness of meat is due to many different attributes including factors during the 
conversion of muscle to meat. Metabolic changes that occur as muscle is converted to meat 
include the switch from aerobic glycolysis to anaerobic metabolism of pyruvate in order to 
maintain a supply of phosphate to produce ATP. Lactate accumulation during this process 
lowers the intracellular pH to about 5.6. As these ATP levels are decreased and calcium 
regulation is decreased, irreversible cross-bridges form between myosin heads and actin, 
causing rigor mortis, which is associated with increased toughness of meat. 
Another contributor to variation of tenderness is increasing connective tissue in 
relation to increasing animal age. Connective tissue is primarily composed of two proteins, 
collagen and elastin (Aberle et al., 2001). During animal maturation, the endomysium, 
perimysium, and epimysium thicken and cross-links form between collagen molecules 
(Robins et al., 1973). The effect of connective tissue on tenderness is called background 
toughness (Aberle et al., 2001). This background toughness increases with animal age and 
the insolubility of the connective tissue proteins makes resolving the increased background 
toughness difficult. 
Changes in muscle fiber properties also affect variation in tenderness. The current 
evidence suggests that the proteolysis of cytoskeletal proteins is the cause of meat 
tenderization during aging. The proteins involved include 1) intermediate filaments such as 
desmin and vinculin 2) intra-myofibril linkages such as titin, nebulin, and troponin-T 3) 
costameric proteins such as vinculin and dystrophin and 4) proteins such as laminin and 
fibronectin are involved in attachment of muscle cells to the basal lamina (Koohmaraie et al., 
2002). There are several endogenous proteolytic systems in muscle, including the cathepsin-
lysosomal system, the ATP-dependent ubiquitin-proteosome system, the calpain-calpastatin 
system, and the matrix-metalloproteinases (Marsh, 1988). There is little evidence that the 
ubiquitin system is involved in postmortem proteolysis due to its ATP-dependency for 
activation (Marsh et al., 1988). The lysosomal system does not appear to be responsible, 
although the decrease in pH would allow for increased activation of cathepsins (Marsh et al., 
1988). However, a lack of myosin degradation in the postmortem myofibril and the 
prevalence of myosin as a substrate for lysosomal enzymes (Koohmaraie, 1992) indicates 
that lysosomal enzymes are not a main protease involved in postmortem proteolysis. 
Postmortem proteolysis is primarily the result of calpain degradation of myofibrillar and 
cytoskeletal proteins (Koohmaraie, 1992; Taylor et al., 1995; Boehm et al., 1998; Wheeler et 
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al., 2000). Additionally, calpastatin, the endogenous inhibitor of calpains, can greatly affect 
calpain mediated degradation of cytoskeletal proteins in postmortem muscle. 
Calpain and Calpastatin Activity in Postmortem Tissue 
As previously stated, calpain degradation of myofibrillar and cytoskeletal proteins is 
responsible for tenderization that occurs during aging of meat postmortem (Koohmaraie, 
1992). More specifically, it is agreed that ^-calpain, rather than m-calpain, plays the primary 
role in tenderization (Boehm et al., 1998; Ilian et al., 2001; Veiseth et al., 2001). 
The first evidence supporting calpain mediated postmortem tenderization was an in 
vitro study that demonstrated the loss of Z-disk structure in calpain-treated skeletal muscle 
myofibrils (Busch et al., 1972). This deconstruction of the Z-disk was attributed to an 
increase in tenderness during aging. When evaluating calpain activity in carcasses, infusion 
of zinc (a calpain inhibitor) into ovine carcasses (Koohmaraie, 1992a) blocked postmortem 
proteolysis and tenderization. Whipple and Koohmaraie (1991) determined that zinc 
inhibited degradation of purified myofibrils that were incubated with m-calpain. 
Additionally, they compared degradation profiles of m-calpain and lysosomally degraded 
myofibrils and determined that the m-calpain degraded myofibrils more closely duplicated 
the degradation profiles of 14 day aged myofibrils. 
Injection of calcium has been used to improve meat tenderness (Wheeler et al., 1993; 
Wheeler et al., 1997). Koohmaraie et al. (1989) determined that calcium infusion of ovine 
carcasses increased postmortem tenderization and correlated to increased proteolysis of 
myofibrillar proteins during postmortem storage. This was hypothesized to be due to 
activation of calpains. Harris et al. (2001) also observed increased sensory panel tenderness 
scores in CaCh-injected beef. They also saw accelerated tenderization in steaks injected with 
CaClz from vitamin E fed cattle compared to CaCla-injected beef from cattle not 
supplemented vitamin E. This accelerated tenderization corresponded to an increase in 
troponin-T degradation at day 1 post-injection (48 hours postmortem). 
Boehm et al. (1998) evaluated the changes that occur in activity and protein profiles 
of p-calpain, m-calpain, and calpastatin during aging. They determined that m-calpain 
activity changed marginally between measurements taken at-death and 7 days postmortem. 
ji-Calpain activity decreased rapidly within the first day and showed almost no activity after 
7 days postmortem. Calpastatin activity also decreased during the 7 day aging period. 
Western blot analysis determined that after 7 days postmortem, intact calpastatin was not 
detectable and the 80 kDa subunit of p-calpain was almost completely in the 76 kDa form. 
m-Calpain was determined not to have autolyzed based on SDS-PAGE, but the small change 
in mass that occurs with m-calpain autolysis is difficult to determine using normal SDS-
PAGE. Proof of m-calpain autolysis must be done through direct sequencing or using an 
antibody that detects the NHz-terminal sequence of m-calpain (Goll et al., 2003). N-terminal 
sequencing was attempted by Boehm et al. (1998) but the N-terminal region of m-calpain 
was blocked. 
Much debate has occurred on the true action of calpastatin in postmortem muscle. Is 
variation in postmortem proteolysis related to inhibition of p-calpain by calpastatin or is it 
due to the fact that calpastatin is a known substrate for calpains (Doumit and Koohmaraie, 
1999), thereby adding another target for p-calpain proteolysis? Activation of calpain causes 
inactivation of calpain, and if calpastatin is being targeted by calpain for proteolysis, 
degradation of key proteins involved in postmortem tenderization may be decreased. 
Additionally, calpastatin can act as a regulator of calpain activity as the interaction between 
calpain and calpastatin is irreversible. Results from Chapter 4 indicate that calpastatin can 
prevent ^-calpain inactivation by oxidation, thus allowing for ^-calpain to be active once 
conditions change to allow activation (i.e. disassociation of (i-calpain/calapstatin complex 
and nonoxidating environment). 
Transgenic mice overexpressing calpastatin were used to observe ^-calpain activity in 
postmortem muscle (Kent et al., 2004). These mice had a 370-fold increase in calpastatin 
activity at death in comparison to control mice. Rate of p-calpain autolysis by day 3 
postmortem was greater for control mice. Autolysis of the |>calpain large subunit from the 
transgenic mice was completed only to the intermediate 78 kDa band. Additionally, desmin 
degradation was reduced in transgenic mice. They concluded from the results that calpastatin 
regulates calpain activity postmortem through inhibitory action as indicated by reduced 
autolysis and degradation of substrates. 
A more recent interest in postmortem proteolysis focuses on its role in water-holding 
capacity. Kristensen and Purslow (2001) tested the hypothesis that water-holding capacity 
increases during aging due to the proteolytic change in the cytoskeletal structure of meat. 
More specifically, greater degradation of desmin, talin, and vinculin has been linked to 
decreased drip loss (Kristensen and Purslow, 2001). Lateral shrinkage that occurs in the 
myofibrils postmortem (Diesbourg et al., 1988) will, due to linkage of the myofibrils to the 
sarcolemma, shrink the muscle cell. This decrease in the muscle cell volume decreases the 
amount of intracellular space available for water. Additionally, shrinkage of the muscle cell 
will increase the pressure in the intracellular space as compared to the extracellular space, 
actually promoting water movement out of the cell. Kristensen and Purslow (2001) 
hypothesized that degradation of these cytoskeletal proteins, which are key in the linkage 
between myofibrils and linkages of costameres, relieve the pressure differences between 
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intracellular and extracellular water compartments and increase intracellular space for water 
storage through the release of the myofibrils from the sarcolemma. 
Melody et al. (2004) observed a lower drip-loss percentage after 96 hours storage in 
porcine psoas major muscle in comparison with semimembranosus and longissimus dorsi. 
This lower drip loss corresponded to faster degradation of desmin observed in the psoas 
major. The psoas major muscle also had lower calpastatin activity by 6 hours postmortem 
and faster p-calpain autolysis as early as 45 min postmortem, which corresponded to a faster 
pH decline, which explains the increased desmin degradation. These results closely relate to 
observations of Kristensen and Purslow (2001) in that greater degradation of cytoskeletal 
protein, particularly those involved in linkage of muscle fibers, created more space for water 
and decreased pressure in the intracellular compartments. 
pH 
One of the most pronounced changes in the conversion of muscle to meat is the pH 
decline from near neutral pH in living muscle to approximately 5.6 in meat. Calpains have a 
pH optimum of 7.5 (Edmunds et al., 1991; Wang and Jiang, 1991). Therefore, it is important 
to understand calpain activity at lower pH conditions as observed in meat. Many studies 
have been conducted to determine if calpain activity is affected by pH, particularly under low 
temperature conditions as observed in chilled carcasses. Koohmaraie et al. (1986) observed 
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that at pH 5.5 to 5.8 at 5°C, ^-calpain activity was 24-28 % of p-calpain activity at pH 7.5 at 
25°C after 90 min incubation. Although pH decreased p-calpain activity, the results from 
this study indicated that ^-calpain can be active in conditions of pH and temperature similar 
to pH and temperature in a carcass. 
Huff-Lonergan et al. (1996) evaluated degradation of five cytoskeletal proteins (titin, 
nebulin, filamin, desmin, and troponin-T) by purified (i-calpain from bovine skeletal muscle 
at pH 5.6 and 4°C and 165 mM NaCl. Immunoblot profiles of the degradation products from 
purified myofibrils were compared to immunoblot profiles of the degradation of the same 
proteins in aged beef steaks. It was determined that ^-calpain was active at conditions 
similar to meat and [i-calpain mediated degradation of these five proteins corresponded to the 
breakdown of these proteins in aged beef steaks. Additionally, steaks were divided into a 
high Warner-Bratzler shear force value and a low Warner-Bratzler shear force value group. 
Steaks from the low shear force value group clearly had faster proteolysis of these five 
proteins than steaks with higher shear force values. 
Melody et al. (2004) observed that porcine muscles with low early postmortem pH 
(psoas major) had earlier |a.-calpain autolysis and inactivation and earlier initiation and 
completed degradation of desmin than muscles with higher early postmortem pH 
(longissimus and semimembranosus). Although the mechanism behind the different pH 
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declines between muscles is not understood, they hypothesized that the differences in pH 
decline occurred due to a faster temperature drop in the psoas major and a higher percentage 
of the myosin heavy chain isoform type I, which may allow for increased calcium 
concentrations in the sarcolemma, which in turn increased postmortem metabolism resulting 
in a faster pH decline. They observed differences in tenderness, where the psoas major had 
the lowest Warner-Bratzler shear force values when compared to the semimembranosus. 
Geesink and Koohmaraie (2000) determined that pH affects stability of calpain. They 
showed that autolyzed porcine skeletal p-calpain activity was more stable (indicated by 
greater activity) at pH values of 6.2 to 6.4 when evaluating pH ranges from 7.6 to 5.6. 
Geesink and Koohmaraie (2000) determined that p-calpain had approximately 70% of initial 
activity after incubation for 30 min at pH 6.2 and approximately 22% of initial activity 
remaining at pH 7.5 indicating a more stable molecule at the lower pH. 
The change in pH has not shown to affect calpastatin inhibition of calpains. Geesink 
and Koohmaraie (1999a) determined that calpastatin inhibition of p-calpain activity was not 
different under pH conditions of 5.7, 6.2, and 7.0 at 25°C. Kendall et al. (1993) determined 
that pH alone did not affect calpastatin inhibition of m-calpain. 
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Ionic strength 
Another change that occurs is the increase in ionic strength from an approximate 
equivalent of 165 mMNaCl in living muscle to approximately equivalent to 295 mMNaCl in 
meat (Winger and Pope, 1980-81). 
Differences in ionic strength have been shown to affect p-calpain activity by 
decreasing the stability of autolyzed p-calpain (Geesink and Koohmaraie, 2000, Li et al., 
2004), thereby decreasing ^-calpain activity as ionic strength increases. Likewise, Li et al. 
(2004) observed loss of autolyzed p,-calpain activity at salt concentrations as low as 100 mM 
KC1 at pH 7.5, and they determined that ionic strengths of 300 mM or greater decreased 
autolyzed ^-calpain activity by 50 to 55% within 5 min. The loss of ja-calpain activity due to 
high salt concentrations (500 mM) was not reversible once the salt had been removed (Li et 
al., 2004). The rate of activity loss was slower at lower ionic strengths (Li et al., 2004). Li et 
al. (2004) hypothesized an ionic strength equal to 100 mMKCl or greater caused 
disassociation of the two m-calpain subunits, allowing for inactivation of the proteinase due 
to the formation of dimers and trimers of the large subunit. 
Kendall et al. (1993) determined that at lower pH conditions (i.e. 5.7) increasing ionic 
strength (200 mM NaCl or greater) decreased calpastatin inhibition of m-calpain. Tompa et 
al. (2001) through the use of overlay blotting techniques indicated the binding of 
phospholipids to domain III is calcium dependent and influenced by ionic strength. At 
higher ionic strengths, decreased binding of phospholipids was observed, which negated the 
ability of lower calcium concentrations to activate calpains, indicating a decrease in m-
calpain activation at higher ionic strengths. 
Other factors affecting calpain/calpastatin activity 
Large differences in tenderness have been observed between cattle containing bos 
indicus genetics compared to cattle with bos taurus genetics indicating that bos indicus cattle 
have less tender meat. Direct comparison of Brahman cattle (bos indicus) and Hereford 
cattle (bos taurus) at slaughter (Wheeler et al., 1990) indicated that there were not differences 
in pH decline, temperature, or ionic strength effects on myofibrillar protein solubility. 
However, Hereford cattle had greater ^-calpain activity at harvest and lower p-calpain 
activity at day 1 postmortem, in addition to lower calpastatin activity at harvest. These 
measurements corresponded to differences in tenderness ratings from a sensory panel and 
Warner-Bratzler shear force values, where steaks from Hereford cattle were more tender than 
steaks from Brahman cattle. They concluded that ^-calpain was more active postmortem due 
to the lower levels of calpastatin activity in the steaks from the Hereford cattle than was 
measured in the steaks from the Brahman cattle. 
The callipyge condition in sheep results in increased muscle hypertrophy of skeletal 
muscle, particularly in the lamb hindquarters. Koohmaraie et al. (1995) evaluated 
postmortem differences between normal and callipyge sheep and observed that in normal 
lambs, shear force decreased throughout aging. Also during aging, degradation of titin, 
nebulin, desmin and troponin-T were observed. Conversely, in callipyge lambs, the shear 
force changes during aging were minimal, and the rate and extent of degradation of the afore 
mentioned proteins were minimal. Additionally, they determined that callipyge lambs had 
greater calpastatin activities after 7 and 21 days postmortem. Delgado et al. (2001) observed 
similar results, where calpastatin activity was greater in callipyge muscle (biceps femoris and 
longissimus) than in normal sheep, but calpastatin was the same in the infraspinatus, which 
does not have increased hyptertrophy in callipyge lambs. 
Ilian et al. (2001) determined that fasting lambs for 1 day prior to harvest caused a 
significant improvement in longissimus tenderness. A correlation was calculated between 
shear force value at day 1 postmortem and p-calpain activity, measured against casein after 
purification with DEAE ion-exchange chromatography from a sample taken at death. The 
negative correlation indicated that the higher the shear force value, the lower the ^-calpain 
activity. Correlations between shear force and m-calpain activity or calpastatin activity were 
not significant. They concluded that ^-calpain and not m-calpain plays a role in postmortem 
meat tenderization. 
Oxidation in postmortem muscle 
Oxidative processes are part of intracellular metabolic functions (Forman et al., 2002) 
including signal transduction pathways and second messenger systems. Oxidation also can 
occur due to pathological stimuli including radiation, air pollutants, pesticides, herbicides, 
and intracellular conditions such as hypoxia, ischemia, and antibiotic therapy (Van 
Steenhouse, 1987). Living cells balance oxidation with antioxidant systems to protect and 
retain cellular function (Thomas and Mallis, 2001). In postmortem tissue, as antioxidants are 
expended, that control is lost and affects the many mechanisms of oxidation important in 
protein functionality in meat products. The effect of oxidation on muscle protein 
functionality js very complex and a relationship exists between extent of oxidation and 
magnitude in the alteration of function of the effected proteins (Xiong, 2000). During aging, 
the protein sulfhydryl content decreases while the protein carbonyl content increases in beef 
myofibrils (Martinaud et al., 1997; Srinivasan and Hultin, 1995) indicating oxidation is 
readily occurring. 
Oxidative processes are known to be major causes of meat quality deterioration in 
traits such as flavor, color, and nutritional composition (Xiong, 2000). Oxidation of lipids 
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are known to be a primary cause of off flavor and autoxidation and oxygen consumption 
allow for the production of metmyoglobin to cause changes in color (Renerre, 1990). The 
effect of oxidation of proteins in relation to protein functionality is currently getting more 
attention (Martinaud et al., 1997). Ooizumi and Xiong (2004) determined that oxidation 
using a nonenzymatic hydroxyl radical generation system consisting of ascorbate, FeClg, and 
H2O2 in chicken myofibrils decreased ability of gel formation in myofibrillar proteins. 
Oxidation of myofibrils resulted in intramolecular cross-linking of the myosin heavy chain 
and modifications to thiol groups at the myosin ATPase active site, which then lead to 
aggregation of myosin molecules (Ooizumi and Xiong, 2004). Changes in gel formation can 
impact texture characteristics and binding strength of processed meats. Decker et al. (1993) 
observed similar effects of metal-catalyzed oxidation in turkey white muscle myofibrillar 
proteins where loss in protein solubility, decreased gel strength, and decreased water-holding 
capacity occurred. In addition of effects of oxidation on processed meat products, Xiong 
(2000) suggested that the oxidative changes in postmortem muscle proteins may contribute to 
postmortem proteolysis ultimately affecting fresh meat characteristics of tenderness and 
water-holding capacity. 
Protein Oxidation 
The oxidative process causes production of reactive oxygen species (ROS). Most 
ROS produced are free radicals, which by definition, are any molecules with an odd number 
of electrons (VanSteenhouse, 1987). Free radicals are formed by the splitting of an organic 
molecule and include superoxide anions, hydrogen peroxide, hydroxyl radicals, singlet 
oxygen, nitric oxide (NO), and perxoyl radicals. If not quenched by an antioxidant, these 
compounds will react with the nearest lipid, protein, carbohydrate, RNA, or DNA molecule, 
altering their structure and function. 
In muscle tissue, high concentrations of oxidizable lipids, heme pigments, transitional 
metal ions, and other oxidative enzymes can serve as precursors or catalysts for the 
production of free radicals (Xiong, 2000). The production and action of these free radicals 
cause physical and chemical changes that can be beneficial to the host cell, particularly by 
killing microbial pathogens, but they are also implicated as mediators of tissue damage and 
cell aging processes that include amino acid destruction, decreases in protein solubility due to 
polymerization, enzyme activity loss, and increases in protein digestibility (Stadtman and 
Oliver, 1991; Agarwal and Sohal, 1994). 
Oxidation of proteins in postmortem muscle tissue occurs primarily from lipid by­
products and metal ions (Xiong, 2000). The reaction from lipid by-products starts with 
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initiation when a free radical associates with a lipid molecule. Polyunsaturated fatty acids 
are the most readily oxidized lipid due to the instability of its structure because of the 
reactivity of unstable double bonds. The second step of oxidation occurs with propagation of 
the lipid free radical where it interacts with an unstable oxygen molecule. The next step 
could occur with the lipid molecule interacting with a protein, removing a hydrogen from the 
protein side chain and passing the odd electron to the protein in a process called hydrogen 
abstraction. A different process could occur that involves the lipid molecule linking to the 
protein molecule in a process called addition. This lipid-protein molecule is still reactive and 
can link with another protein and form what is formally titled a "complex" (Xiong, 2000). 
These complexes can interact causing polymerization. Metal ions such as Fe2+ and Cu2+ are 
also strong catalysts of protein oxidation. This particular oxidation is site specific as side 
chains of aromatic and basic amino acids at the metal binding sites are specific targets 
(Stadtman and Oliver, 1991). Uchida et al., (1992) studied the effect of the copper/HzO? and 
iron/HzOz oxidizing systems and determined that these oxidizing agents caused the protein to 
polymerize or degrade. Copper mainly targeted aromatic and basic amino acids where 
effects of iron were more variable indicating possible difference in the oxidizing mechanism 
of the two metal ions. 
Reactive oxygen species tend to target sulfhydryl containing amino acids on proteins 
such as cysteine (Freeman and Crapo, 1982). Cysteine is probably the most susceptible 
amino acid residue and one of the first to be oxidized (Xiong, 2000). The nucelophilic role 
of sulfhydryls on cysteines are well known and the redox state of active site cysteine in both 
transfer/addition reactions (S-transferases, glyceraldehydes 3-P dehydrogenase, glutathione 
reductase) and in peptidase activity (caspases, papain, and calpains) is critical for 
functionality (Giles et al., 2003). The nucelophilicity of these cysteines are usually increased 
by ionization of the thiol to the thiolate anion, which increases susceptibility of the residue to 
oxidation (Gilbert, 1990). 
Normal cellular homeostasis helps to maintain fully reduced states of the cysteine 
residues in order to maintain full functionality, which includes regulation of proteins 
involved in catalysis, regulation, electron transfer, and protein structure. Therefore 
irreversible oxidation can cause complete loss of function of these proteins. However, 
reversible oxidation of a reactive cysteine residue can play a role in regulation and function 
of proteins (Ghezzi and Bonetto, 2003). 
S-thiolation, S-nitrosylation, and irreversible oxidation are oxidative modifications of 
protein sulfhydryls that can occur (Gilbert, 1990). S-thiolation and S-nitrosylation may result 
from ROS action. Since both modifications are reversible, they may play important 
regulatory roles in cell metabolism during times of increased oxidative stress. S-thiolation 
has long been thought to start with protein thiol disulfide-exchange. 
1) Protein-S + RSSR ++ protein-S-SR + RS-
However, this reaction occurs rather slowly (Gilbert, 1990) and requires higher RSSR 
concentrations, so is most unlikely in intact cells. Therefore other mechanisms have been 
proposed (Thomas and Mallis, 2001) that include: 
2) Protein-SH- + R» —• protein-S* + RH (thiolate anion) 
3) Protein-S- + ROO k protein-S* + ROO- (thiyl radical) 
4) Protein-SH + HOOH —• protein-SOH + HOH (sulfenic acid) 
These products of thiolation are reversible and can revert to the reduced form. Many 
regulatory proteins and enzymes form reversible disulfides and some signal transduction 
proteins and transcription factors determine the redox state of a cell by forming 
intramolecular disulfides. 
Thiolation can continue to occur to the point where it is irreversible. Sulfinic and 
cysteic acids are formed (Thomas and Mallis, 2001) in the absence of antioxidants. These 
reactions are: 
5) protein-SOH + 0% k Protein-S02H (Sulfinic acid) 
6) Protein-SOaH + 0% k Protein-SC^H (Cysteic or sulfonic acid) 
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These irreversibly oxidized sulfhydryls can accumulate and affect normal cellular functions. 
S-nitrosylation is a mechanism that is not well understood, but has been found to be 
quite similar to S-thiolation. It occurs when a nitric oxide group is transferred to a sulfhydryl 
on a protein, usually targeting cysteine and tyrosine residues (Stamler, 1994). Nitrosylation 
is an important mechanism of redox regulation and NO modulation of the activity of several 
proteins (Jaffrey et al. 2001; Hess et al., 2001). The primary mechanism proposed: 
Protein-SH + NO+ —• Protein-SNO + H+ 
Nitrosothiols (RSNO) produced from this reaction are quite labile and can promote 
disulfide formation (Broillet, 1999). Nitrosothiols are formed under a wide variety of 
environments that include both aerobic and anaerobic conditions. Specificity for 
nitrosylation is thought to be through localization of nitric oxide synthase (NOS), which 
produces nitric oxide (NO) from the guanido nitrogen of L-arginine (Broillet, 1999). The 
location of NOS may be in proximity to targets of NO. Actual nitrosylation due to NO 
depends upon NO concentration, the redox status of the environment, and the susceptibility 
of target sites for modification, which helps explain the specificity of S-nitrosylation of 
cysteine residues to direct protein functionality. The reversibility of RSNO is largely 
unknown. It is hypothesized that reductases may be responsible for some of the detachment 
of NO from thiols (Hausladen et al., 1996). 
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Besides S-thiolation of sulfhydryls to sulfonic or cysteic acid, other irreversible 
oxidation mechanisms of proteins include carbonylation and nitration (Ghezzi and Bonetto, 
2003). Generally, irreversible modifications are responsible for permanent loss of function 
of the damaged proteins which are then degraded (Berlett and Stadtman, 1997; Dean et al., 
1997). 
Carbonylation is used as a marker of protein oxidation and its measurement gives an 
indication as to the extent of oxidation has occurred (Xiong, 2000). Carbonylation may 
occur via direct oxidation of some amino acid side chains, particularly histidine, arginine, 
and lysine, fragmentation of the peptide backbone, a reaction with reducing sugars, or by 
reaction with products of lipid oxidation. Carbonylation is named for a carbon atom bound 
to an oxygen molecule though a double bond. Cross-linking of proteins and peptide scission 
can occur readily after formation of carbonyls which can result in polymerization, 
aggregation, and possibly insolubilization of proteins. Polymerization and aggregation can 
occur when oxidatively induced unfolding of proteins can expose hydrophobic residues 
causing protein interactions (Gardner, 1979). 
Nitration of tyrosine forms 3-nitrotyrosine (3-NT), which is used as a marker of 
irreversible protein damage. Increased levels of 3-NT has been linked to diseased states that 
include Alzheimer's disease, Parkinson's disease, and atherosclerosis (Ghezzi and Bonetto, 
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2003). A role for nitration in cell signaling is currently becoming better understood, as it is 
thought to affect protein kinase activities. Nitration has been shown to both inhibit (Hellberg 
et al., 1998) and stimulate (Li et al., 1998) tyrosine phosphorylation. 
Oxidation by H2O2 
A thiol (SH) does not react at physiologically significant rates with a hydroperoxide 
unless the reaction is catalyzed. However, thiolates (S-) react quickly with hydroperoxide 
under the general reactions series where sulfenic acid is the main product (Forman et al., 
2004): 
Protein-S- + H2O2 • Protein -SO- + H2O + H+ (Sulfenic acid) 
Protein-SO- + Protein'-SH * Protein-SS-Protein' + OH-
Sulfenic acid modification is reversible, thus, the original thiolate can be restored by 
exchange with another thiolate (Saurin et al., 2004). 
Protein-S S -Protein + Protein-S- —*Protein-S- + Protein-S S-Protein 
This mechanism of H2O2 follows the basic principles of oxidation described previously with 
hydrogen abstraction and addition. 
Since H2O2 is widely produced in cells, it is often used as the oxidant in research on 
oxidation-reduction mechanisms in cell biology. Saurin et al., (2004) evaluated sulfenic acid 
formation in mammalian tissues under elevated H2O2 conditions. It was determined that 
many important proteins are modified in rat hearts upon H2O2 exposure, including myosin 
heavy chain , actin, tropomyosin 1 a chain, troponin-T, myosin light polypeptide 3, and 
myoglobin. However, when evaluation of concentration and duration effects of H2O2 was 
conducted, there was a gradual decrease in the amount of sulfenic acid as H2O2 concentration 
increased. It was discussed that the irreversible sulfinic and sulfonic acids were most likely 
being produced. Production of sulfenic acid was also decreased the greater the exposure time 
to H2O2, which they also attributed to a production of sulfinic and sulfonic acids. It was 
discussed that heart muscle may have a maximum concentration of H2O2 it can tolerate 
before irreversible tissue injury can occur. 
Oxidation of cysteine proteases and calpains 
As cysteine is a known target for oxidation, much of the research has shifted to the 
effects of oxidation on cysteine proteases. A cysteine residue in the active site of these 
proteases acts as a nucleophile working with a histidine residue acting as a proton donor 
resulting in a release of an amine product from its target. This active site cysteine can be 
readily oxidized as shown in archaeal GAPDH (Isupov et al., 1999) and pyrrolindone 
carboxyl peptidase (Singleton et al. 1999). Implications of the active site cysteine oxidation 
have been shown to be important in caspase enzymes, which are a major component in the 
apoptotic pathway. Oxidative changes to caspase occur primarily through NO and free iron 
(Kim et al., 2002). Nitrosylation of the active site cysteine residue inhibits proteolytic 
activity (Zeigler et al., 2003). However, Mannick et al. (2001) suggest that this nitrosylation 
of caspase is not stable and is a possible method of reversible activation by denitrosylation 
indicating that oxidation of the active site cysteine residue is used to control enzymatic 
activity within the cell. 
Oxidation of the active site cysteine has also been shown to be involved in direct 
activation of hydrolytic enzymes as Bourne et al. (2000) observed in agrobacterial esterase. 
A disulfide bond between two adjacent residues needs to be formed to allow for binding of 
the tetrahedral intermediate formed from the active site triad of cysteine, histidine, and 
asparagine which stabilizes that protein for further activation. 
Since calpains are cysteine proteases, oxidation may affect calpain activity in various 
ways. Most research has determined that oxidation decreases the ability of fx-calpain to 
degrade its substrates (Guttmann and Johnson, 1998; Koh and Tidball, 2000; Michetti et al., 
1995; Rowe et al., 2004b). Guttman et al. (1997) evaluated p-calpain activity in the presence 
of H2O2 and observed that proteolytic cleavage of a fluorogenic peptide Suc-Leu-Leu-Val-
Tyr-AMC and microtubule associated protein tau by fx-calpain was strongly inhibited. They 
suggested that it was not activation of ^-calpain in oxidatively stressed diseased states, but in 
fact, inactivation of g-calpain causing an increase in calpain substrates and accumulation of 
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autolyzed ^-calpain that was a mechanism behind some of the disease conditions that are 
observed in Alzheimer's disease and ischemia. 
Many studies have shown a stimulation of calpain activity following oxidative stress. 
Ray et al. (2000) observed increased m-calpain degradation of myelin associated protein after 
peroxide treatment in C6 glioma cells. Spectrin was degraded by (i- or m-calpains 
(unspecified) in oligodendrocytes after oxidative stress (McCracken et al., 2001). This 
activation of calpains may be dose dependent as Pronzato et al. (1993) observed that carbon 
tetrachloride, as an oxidizing agent, in low doses allowed for calpain activation, where higher 
doses inhibited calpain activity. It is also postulated that calpain protein substrates, when 
oxidized, can be preferentially degraded. No studies exist evaluating this hypothesis directly, 
but an in vitro study by Zolotarjova et al. (1994) demonstrated selective calpain degradation 
of oxidized Na+/K+-ATPase. Reversible inactivation has also been thought to occur in 
calpain, similar to caspases, where oxidation is used to regulate calpain activity. In 
ischemia/reperfusion injury, increases in calpain activity have been observed (Numar et al., 
1996; Tolnai and Korecky, 1986). Kohli et al. (1997) observed increasing calpain activity in 
cold-preserved rat livers, livers going through a rewarming phase, and livers subjected to 
reperfusion in an experiment designed to mimic ischemia/reperfusion injuries. 
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Oxidative stress is often combined with a Ca2+-influx into the cells (Hare, 2003) that 
is readily observed in anoxia/reoxygenation injury (Snowdowne et al., 1985). This influx of 
calcium is partially due to the effects of oxidation on the regulation of the ryanodine receptor 
and the sarcoplasmic reticulum calcium ATPase (Stamler and Meissner, 2001). In the 
ryanodine receptor, out of a total 364 cysteine residues, 84 provide free sulfhydryl groups 
indicating a large potential for oxidation (Xu et al., 1998). Calpains may be activated as a 
consequence of this increased intracellular calcium and not by oxidation effects. 
Rowe at al. (2004a, b) evaluated how oxidative conditions in meat initiated by 
irradiation early postmortem caused inhibition of ^-calpain activity slowing the rate of 
proteolysis occurring during aging, thereby decreasing tenderization. Carbonyl content of 
sarcoplasmic proteins and myofibrillar proteins was measured (Rowe et al., 2004a) up to 14 
days post irradiation in beef steaks that were irradiated and compared against steaks that were 
not irradiated. Irradiated steaks had significantly higher carbonyl content in both 
sarcoplasmic and myofibrillar proteins up to day 7 post irradiation. Western blots for 
oxidized sarcoplasmic and myofibrillar proteins from irradiated and non-irradiated steaks 
indicated that carbonyl content was increased in the irradiated steaks as indicated by the 
detection of more bands. A comparison was made based on the animal diet containing 
vitamin E and a noticeable decrease in oxidized sarcoplasmic proteins was observed in 
irradiated steaks from vitamin E supplemented animals. Vitamin E did not appear to affect 
oxidation of proteins in non-irradiated steaks. A positive correlation existed between the 
carbonyl measurements and the Warner-Bratzler shear force measurements, indicating higher 
carbonyl content was associated with a higher shear force. Calpastatin activity was higher in 
the irradiated steaks than in the non-irradiated steaks, which was attributed to a decrease in 
fx-calpain activity resulting in less ^-calpain mediated degradation of calpastatin. In addition 
to vitamin E supplementation decreasing protein oxidation of sarcoplasmic proteins, Rowe et 
al., (2004b) demonstrated that g-calpain activity was recoverable once reducing conditions 
were introduced, thereby providing a basis for antioxidant use in meats. Antioxidants are 
currently becoming more prevalently used in the meat industry to increase shelf life by 
preventing oxidation of lipids that cause rancidity. Harris et al. (2001) evaluated effects of 
antioxidants on tenderization and determined that increased levels of alpha-tocopherol in 
beef through supplemental vitamin E in the diet in combination with injecting steaks with 
CaCla exhibited a faster rate of decline of Warner-Bratzler Shear Force values and a faster 
rate of troponin-T degradation. Additionally, Rowe at al. (2004b) observed an increase in the 
rate of troponin-T degradation in beef from calves fed a diet supplemented with vitamin E. 
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Summary 
This literature review addressed the topics of calpains, calpastatin, meat quality, and 
oxidation. As the literature was collected, it is apparent that calpain activation is affected by 
many factors. Intracellular environment clearly plays a role in the extent of calpain 
activation, these factors of environment include pH and ionic strength. Clearly oxidation of 
calpains is an area that needs greater understanding, particularly in conditions that also affect 
calpain activity. Additionally, although calpastatin activity has been determined to play a 
role in many calpain processes, the mechanism of calpastatin inhibition of calpains needs to 
be elucidated in order to get a complete understanding of the activity of calpains and their 
roles in cellular metabolism and postmortem proteolysis. 
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EFFECT OF pH AND IONIC STRENGTH ON |u- AND m-CALPAIN INHIBITION 
BY CALPASTATIN1'2 
A paper published in Journal of Animal Science 83: 1370-1376 
K.R. Maddock3, E. Huff-Lonergan, L.J. Rowe, and S.M. Lonergan4 
Abstract 
The objectives of this study were to determine the extent to which pH and ionic 
strength influence //- and m-calpain activity and the inhibition of calpains by calpastatin. 
Calpastatin, //-calpain, and m-calpain were purified from at-death porcine semimembranosus. 
//-Calpain or m-calpain (0.45 U) were incubated with the calpain substrate Suc-Leu-Leu-Val-
Tyr-7-amino-4-methyl coumarin in the presence of calpastatin (0, 0.15, or 0.30 U of calpain 
inhibitory activity) under the following pH and ionic strength conditions: pH 7.5 and 165 
mMNaCl or 295 mMNaCl; pH 6.5 and 165 mMNaCl or 295 mMNaCl; and pH 6.0 and 165 
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slonerga@iastate.edu). 
mMNaCl or 295mMNaCl. The reactions were initiated with addition of 100 juM (//-calpain) 
or 1 mMCaC12 (m-calpain), and calpain activity was recorded at 30 and 60 min. //-Calpain 
had the greatest (P < 0.01) activity at pH 6.5 at each ionic strength. Higher ionic strength 
decreased //-calpain activity (P < 0.01) at all pH conditions. Inhibition percent of //-calpain 
by calpastatin was not affected by pH; however, it was influenced by ionic strength. 
Inhibition of //-calpain by calpastatin was higher (P < 0.01) at 295 mMNaCl than at 
165 mM NaCl when 0.3 units of calpastatin were included in the assay. Activity of m-
calpain was greater (P < 0.01) at pH 7.5 than at pH 6.5. m-Calpain activity was not detected 
at pH 6.0. Inhibition of m-calpain was greater (P < 0.01) when 0.15 and 0.3 U calpastatin 
were added at pH 6.5 than 7.5 at 165mMNaCl, whereas percentage inhibition of m-calpain 
was greater (P < 0.01) at 295 mM than 165 mMNaCl at pH 7.5 and 6.5. These observations 
provide new evidence that defines further the influence of pH decline and increased ionic 
strength on //-calpain, m-calpain, and calpastatin activity, thereby helping to more accurately 
define a role for these enzymes in the process of postmortem tenderization. 
Key words: Calpain, Calpastatin, Ionic strength, Proteolysis, pH 
Introduction 
Changes in muscle intracellular environment occurring early postmortem are known 
to influence meat quality. One of the most pronounced changes is the pH decline from near 
neutral pH in living muscle to approximately 5.6 in meat. Another change that occurs is the 
increase in ionic strength from an approximate equivalent of 165 mMNaCl in living muscle 
to an approximate equivalent of 295 mMNaCl in meat (Winger and Pope, 1980-81). 
The calcium activated proteinases, calpains, are responsible for much of the 
postmortem proteolysis of myofibrillar and cytoskeletal proteins. This proteolysis is 
responsible for the increase in tenderness observed in meat during postmortem storage (Goll 
et al., 1992; Koohmaraie, 1992a; Koohmaraie et al., 2002). Calpain activity is influenced by 
intracellular environmental factors, including calcium concentration, pH, ionic strength, and 
calpastatin (the endogenous inhibitor specific for calpains). Calpains have a pH optimum of 
7.5 (Edmunds et al., 1991; Wang and Jiang, 1991). An increase in ionic strength has been 
shown to decrease p-calpain activity by decreasing the stability of autolyzed ^-calpain 
(Geesink and Koohmaraie, 2000, Li et al., 2004). The effects of the combination of pH and 
ionic strength on calpain activity in the presence of calpastatin have not been elucidated. 
Therefore, the hypothesis of this study was that postmortem pH and ionic strength affects the 
activity of |> and m-calpain and the inhibition of calpains by calpastatin. For this reason, the 
first objective of this study was to determine the extent to which pH and ionic strength 
influence g-and m-calpain activity. The second objective was to determine the extent to 
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which pH and ionic strength influence the ability of calpastatin to inhibit the activity of n- or 
m-calpain. 
Materials and Methods 
Purification of calpastatin, ju-calpain, and m-calpain. 
Calpastatin, ^-calpain, and m-calpain were purified from porcine skeletal muscle 
based on the procedures outlined by Thompson and Goll (2000) with minor modifications. A 
2-kg porcine semimembranosus sample was taken from a market barrow approximately 25 
min after exsanguination. The muscle was immediately ground and homogenized in six 
volumes of ice cold buffer containing 10 mMEDTA, 0.1% (vol/vol) p-mercaptoethanol 
(MCE), and 100 mMTris-HCl, pH 8.3. This buffer also included protease inhibitors (2.5 \xM 
trans-Epoxysuccunyl-L-leucylamido- [4-guanidino] butane (E-64), 0.1 mg/mL ovomucoid 
trypsin inhibitor, and 0.2 mMphenylmethylsulfonylfluoride [PMSF]). The homogenate was 
centrifuged at 9750 x g at 4°C for 30 min. The supernatant was filtered through cheesecloth 
and proteins were salted out between 0 and 45% ammonium sulfate saturation. Proteins were 
collected at 9750 x g at 4°C for 30 min, resuspended in 1 mMEDTA, 0.1 % MCE, 40 mM 
Tris-HCl, pH 7.4 (TEM), stirred overnight at 4°C, and dialyzed against TEM. The sample 
was loaded on a Q-Sepharose Fast Flow (Amersham Biosciences, Piscataway, NJ) anion-
exchange column (900 mL) that had been previously equilibrated in TEM. Using a gradient 
of 0 to 500 mMKCl in TEM (total volume 4,500 mL), porcine calpastatin, p-calpain, and m-
calpain were eluted in three separate peaks from the column (calpastatin eluted between 90 
and 150 mMKCl, ^-calpain between 160 and 190 mMKCl, and m-calpain between 250 and 
280 mMKCl). 
Purification of calpastatin. 
Fractions containing calpastatin activity were pooled and further purified using 
methods described by Thompson and Goll (2000) with modifications from Geesink and 
Koohmaraie (1998). The sample was heated at 100°C for 20 min, chilled on ice, and 
centrifuged at 9750 x g at 4°C for 30 min. Calpastatin was further purified using successive 
chromatography over Phenyl Sepharose 6 Fast Flow (Amersham Biosciences, Piscataway, 
NJ), Blue Sepharose 6 Fast Flow (Amersham Biosciences, Piscataway, NJ), and EMD 
TMAE 650 S (EM Science, Gibbstown, NJ). Purified calpastatin consisted only of a 68 kDa 
band when analyzed by SDS-PAGE and had a specific activity of 365 U/mg protein. One 
unit of calpastatin activity was defined as the ability to inhibit one unit of m-calpain 
caseinolytic activity (Koohmaraie et al., 1995). 
Purification of //- and m-calpain. 
(j.-Calpain and m-calpain were purified according to the methods of Thompson and 
Goll (2000) with minor modifications. Fractions from the Q-sepharose column containing p-
calpain activity were pooled. Pooled |n-calpain was purified using successive 
chromatography over a Phenyl Sepharose 6 Fast Flow (Amersham Biosciences, Piscataway, 
NJ), Butyl Sepharose 4 Fast Flow (Amersham Biosciences, Piscataway, NJ), EMD TMAE 
650 S (EM Science, Gibbstown, NJ), and DEAE-TSK Toyopearl (Supelco, Bellefonte, PA). 
Purified p-calpain had a specific activity of 75 U/mg protein. One unit of calpain was 
defined as the amount of calpain required to increase the absorbance at 278 nm of the 
supernatant by one unit due to the release of trichloroacetic acid-soluble polypeptides 
resulting from the digestion of casein (Koohmaraie, 1990). Fractions from the Q-sepharose 
column containing m-calpain activity were pooled and purified using successive 
chromatography over a Phenyl Sepharose 6 Fast Flow (Amersham Biosciences, Piscataway, 
NJ), Reactive Red 120 (Sigma, St. Louis, MO), and DEAE-TSK Toyopearl (Supleco, 
Bellefonte, PA). Purified m-calpain had a specific activity of 186.4 U/mg protein. The 
purified p-calpain, m-calpain, and calpastatin were stored in TEM with the addition of 1 mM 
sodium azide at 4°C. 
Calpain Activity Assays 
The technique used in this experiment is a sensitive activity assay using a calpain 
substrate, Suc-Leu-Leu-Val-Tyr-7-amino-4-methyl coumarin (Bachem; Torrence, CA; 10 
mg/mL in dimethyl sulfoxide) (Sasaki et al., 1984). Although the use of this specific peptide 
as a substrate for g-calpain and m-calpain allows for highly controlled experiments, it does 
not represent the diversity of all the potential calpain substrates. It should be noted that the 
substrate concentration used is quite close to the Km for g-calpain (Saski et al., 1984). 
Therefore, the reaction was occurring under first order conditions, rather than zero order 
conditions that occur with protein substrates. The Km of protein substrates for calpains tends 
to be in the low \iMranges (Goll et al., 2003). Highly purified calpains (|i- or m-calpain; 
0.45 units caseinolytic activity) were incubated with 170 \xM Suc-Leu-Leu-Val-Tyr-AMC in 
either the presence of highly purified calpastatin (0.15, or 0.30 units measured against 0.45 
units of m-calpain caseinolytic activity) or 0 units of calpastatin under the following 
conditions: 1) pH 7.5, 165 mMNaCl; 2) pH 7.5, 295 mMNaCl; 3) pH 6.5, 165 mMNaCl; 4) 
pH 6.5,295 mMNaCl; 5) pH 6.0,165 mMNaCl; or 6) pH 6.0,295 mMNaCl. The buffers 
were either 50 mMHEPES (pH 7.5 and 6.5) or 50 mM2-(4-morpholino)-ethane sulfonic acid 
(MES) (pH 6.0). Dithiothreitol (DTT; 1 mM final concentration) was added before the 
addition of calcium to ensure fully reduced conditions. Reactions were initiated with the 
addition of 100 pMCaClz (fi-calpain) or 1 mM CaCh (m-calpain). Three replications of 
each pH, ionic strength, and calpastatin combination were conducted. Calpain activity and 
percent inhibition by calpastatin (percent inhibition = 1-(calpain activity without calpastatin 
calpain activity with calpastatin) * 100) were measured at regular intervals from 0 
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(immediately prior to the addition of CaCla) to 60 min in a TD-700 fluorometer (Turner 
Designs, Sunnyvale, CA) using an excitation wavelength of 380 nm and an emission 
wavelength of 460 nm. Standard curves were generated for each experiment using 7-amino-
4-methyl coumarin (AMC) of known concentrations. A control with calcium (without the 
addition of calpain) for each pH and ionic strength condition was conducted to determine if 
calcium affected the fluorescence of the peptide. An EDTA control (20 mMEDTA final 
concentration added prior to addition of calpain and calcium) was included for each pH and 
ionic strength condition and used for the baseline. 
In order to ensure that pH and ionic strength did not directly influence the peptide, 
assays were also conducted with the enzyme carboxypeptidase Y (Calbiochem, La Jolla, 
CA). Carboxypeptidase Y has a pH optimum of pH 5.5 to 6.5, stability up to pH 8.0, and 
Suc-Leu-Leu-Val-Tyr-7-amino-4-methyl coumarin is a substrate for this enzyme (Stennicke 
et al., 1994). In these assays, carboxypeptidase Y was added in place of p- or m-calpain at 
0.5 pL (0.0045 \lM final concentration). Comparison of activity measured in the assays at 
pH 7.5, 6.5, and 6.0, as well as ionic strength of 165 mMNaCl and 295 mMNaCl, was done 
to determine if these environmental conditions changed the susceptibility of the peptide to 
proteolysis. 
81 
SDS-PAGE Gel System and Western Blotting 
Samples used for western blotting of p-calpain autolysis were prepared by removing 
20 |xL from the fluorescence assay (pH 7.5, 6.5, and 6.0; 165 mMNaCl; 0 units calpastatin) 
at 5-min increments for 25 min. This experiment included two replications. Each aliquot was 
added to 10 }iL of sample buffer tracking dye solution (3 mMEDTA, 3% SDS, 20% 
glycerol, 0.003% pyronin Y, and 30 mMTris-HCl, pH 8.0 (Wang, 1982) and 0.1% 13-
mercaptoethanol. Gel samples were heated at 50°C for 20 min, and subsequently frozen to -
80°C until analysis. Samples were fractionated using 9% polyacrylamide separating gels and 
transferred to a membrane (Melody et al., 2004). A sensitive chemiluminescent system (ECL 
Plus kit; Amersham Biosciences, Piscataway, NJ) was used to detect labeled protein bands 
using a charged coupled device (CCD) camera (FluroChem 8800; Alpha Innotech 
Corporation, San Leandro, CA) and FluorChem IS-800 software (Alpha Innotech 
Corporation, San Leandro, CA). 
Statistical Analysis 
Data were analyzed using a split-split plot design. The whole plot was pH (7.5, 6.5, 
or 6.0). The split plot was ionic strength (165 mMNaCl or 295 mMNaCl). The split-split 
plot was calpastatin (0, 0.15, or 0.30 units). The experimental unit was each cuvette placed 
in the fluorometer. Calpain activity at 30 and 60 min was analyzed using PROC MIXED of 
SAS (SAS Institute, Inc., Cary, NC). Least squares means were separated using tests of 
effect slices and significance was defined as P < 0.05. 
Results and Discussion 
Carboxypeptidase Y activity control 
Ionic strength and pH conditions used in these experiments did not alter susceptibility 
of the calpain substrate to proteolysis. Fluorescence at pH 7.5 and 165 mMNaCl was 
defined as 100% of carboxypeptidase Y activity. Fluorescence at pH 6.5 and 165 mMNaCl 
was 97.2% of activity, pH 6.0 and 165 mMNaCl was 99.2 %, pH 7.5 and 295 mMNaCl was 
100.3%, pH 6.5 and 295 mMNaCl was 97.3%, and pH 6.0 and 295 mMNaCl was 99.7% 
after 60 min. It was concluded that the calpain substrate was not affected (P > 0.50) by the 
differing pH and ionic strength conditions and was appropriate to use for our study. 
ju-calpain activity 
At both 165 mMNaCl and 295 mMNaCl, p-calpain activity was greater (P< 0.05) at 
pH 6.5 than 7.5 or 6.0 (Table 1). The slope of the rate of hydrolysis of the peptide by p-
calpain during the first five minutes indicates that, at pH 6.5, p-calpain was more active than 
at pH 7.5. This is consistent with Geesink and Koohmaraie (2000), who found that autolyzed 
porcine skeletal p-calpain activity was more stable (indicated by greater activity) at pH 
values of 6.2 to 6.4 when evaluating pH ranges from 7.6 to 5.6. In order to understand the 
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mechanism underlying the greater activity of p-calpain at pH 6.5, g-calpain autolysis was 
examined using western blots. Appearance of the 78 and 76 kDa immunoreactive bands 
(Figure 1) indicated that autolysis occurred in all pH conditions; yet the rate of autolysis 
within the first 5 min was slowest at pH 6.5. p-Calpain was almost completely autolyzed by 
20 min as shown by the less intense 80 kDa band at pH 7.5 than in samples incubated at pH 
6.5. In contrast, the intact 80 kDa band of p-calpain in the pH 6.5 incubation was still 
relatively more intense at 25 min, indicating less autolysis had occurred during the entire 25-
min incubation. The more limited autolysis at pH 6.5 most likely contributed to the greater 
p-calpain activity remaining at 30 and 60 min compared to the other pH incubations. This is 
important because autolysis of p-calpain has been shown to lead to a loss of activity 
(Koohmaraie, 1992b; Edmunds et al., 1991). Geesink and Koohmaraie (2000) determined 
that p-calpain had approximately 70% of initial activity after incubation for 30 min at pH 6.2 
and approximately 22% of initial activity remaining at pH 7.5. In the current study, |> 
calpain autolyzed more rapidly at pH 7.5, which resulted in less active p-calpain present in 
the assay to degrade the peptide at the later time points. 
Autolysis observed at pH 6.0 shows greater intensity of the 78 kDa autolysis product. 
Very little 78 kDa autolysis product was detected at pH 7.5 or 6.5 at all time points. This 
contrast indicates that pH affects the accumulation of the 78 kDa autolysis product. 
Koohmaraie et al. (1986) observed that, in conditions of pH 5.5 to 5.8 at 5°C, p-calpain had 
24-28% of its activity after 90 min at pH 7.5 at 25°C, indicating less proteolytic activity at a 
lower pH. A rapid pH decline in postmortem muscle also reduces p-calpain activity (Claeys 
et al., 2001), and has been shown to decrease the degradation of troponin-T (Lonergan et al., 
2001). Melody et al. (2004) observed that porcine muscles with low early postmortem pH 
(psoas major) had earlier p-calpain autolysis and inactivation and earlier degradation of 
desmin than muscles with higher early postmortem pH (LM and semimembranosus). 
Additionally, moderate rates of postmortem pH decline (pH of 5.8 to 6.2 at 3 h) have been 
shown to produce the most tender beef loin steaks, whereas rapid rates (pH of 5.5 at 3 h) and 
slow rates (pH 6.8 at 3 h) of postmortem glycolysis produced less tender meat (Marsh et al., 
1987). The novel observations in the current study indicated greater p-calpain activity at the 
intermediate pH (6.5) than pH 7.5 and 6.0 could help to explain the tenderization effects 
reported by Marsh et al. (1987). If the pH decline is rapid, p-calpain activity is diminished 
due to the lower pH. If postmortem glycolysis is slow and the pH does not decline as 
rapidly, p-calpain may autolyze earlier postmortem, thereby losing proteolytic activity earlier 
and not allowing for maximal proteolysis. Thus, intermediate pH decline allows more 
proteolysis and slower completion of autolysis, therefore ultimately allowing for greater 
postmortem protein degradation and increased tenderization. 
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p-Calpain was more active (P < 0.01) at 165 mMNaCl than at 295 mMNaCl under all 
experimental conditions. Thus, it is expected that p-calpain activity will be reduced as 
intracellular ionic strength increases in postmortem muscle. Geesink and Koohmaraie (2000) 
also demonstrated that increased ionic strength decreased activity and stability at 
concentrations of NaCl as low as 100 mM. Likewise, Li et al. (2004) observed irreversible 
loss of autolyzed p-calpain activity at salt concentrations as low as 100 mMKCl at pH 7.5. 
They determined that ionic strengths of 300 mM or greater decreased autolyzed p-calpain 
activity by 50 to 55% within 5 min. The rate of activity loss was slower at lower ionic 
strengths (Li et al., 2004). 
m-calpain activity 
In contrast to p-calpain, m-calpain activity was greater (P < 0.05) at pH 7.5 than pH 
6.5 (Table 2). Dayton et al. (1976) and Edmunds et al. (1991) determined the optimum pH of 
porcine muscle m-calpain to be 7.5. In the current study, no measurable activity of m-calpain 
was observed at pH 6.0 at either ionic strength. m-Calpain was more active (P < 0.01) at 165 
mMNaCl than 295 mMNaCl (Table 2). This ionic strength effect was greater than the 
differences observed for p-calpain. At pH 7.5, the increase in ionic strength decreased (i-
and m-calpain activity by 43.1% and 83.7 % respectively. Li et al. (2004) observed similar 
effects of ionic strength on autolyzed m-calpain, and they hypothesized an ionic strength 
equal to 100 mMKCl or greater caused disassociation of the two m-calpain subunits, 
allowing for inactivation of the proteinase due to the formation of dimers and trimers of the 
large subunit. 
The activities of p- and m-calpain observed with regard to pH may be evidence for a 
difference in the roles of p- and m-calpain in postmortem muscle. It has been hypothesized 
that p-calpain is the protease primarily responsible for the postmortem degradation of 
myofibrillar and cytoskeletal proteins resulting in tenderization of meat, whereas the role of 
m-calpain may be limited based on its high calcium requirement. The results from this study 
also indicate a more important role for p-calpain in postmortem muscle, as p-calpain activity 
was measured at pH 6.0, whereas no m-calpain activity was detected. Additionally, although 
the higher ionic strength did decrease p-calpain activity, m-calpain activity was diminished 
to a greater extent by the increase in ionic strength. 
ju-calpain inhibition by calpastatin 
In porcine muscle, the ratio of calpastatin activity to p-calpain activity is 
approximately 1.5:1 (Ouali and Talmant, 1990). In the current study, the ratio of calpastatin 
to calpain added to the assays was 1:3 and 2:3 in order to evaluate the effect of calpastatin on 
calpain without the occurrence of complete inhibition. Calpastatin inhibited (P < 0.001) p-
calpain activity (Table 3), but percent inhibition was not altered by pH. This is consistent 
with results observed by Geesink and Koohmaraie (1999). Percent inhibition of p-calpain by 
calpastatin was greater at 295 than at 165 mMNaCl at pH 7.5, 6.5, and 6.0 when the higher 
level of calpastatin (0.3 units) was added to the assay. An increase in ionic strength in 
postmortem muscle was predicted to increase the inhibitory efficiency of calpastatin, 
however there were no significant differences in percent inhibition between 165 and 295 mM 
NaCl when 0.15 units of calpastatin were added to the assay. In general, the percent 
inhibition is numerically greater at 295 than 165 mMNaCl when the lower level of 
calpastatin was present. The lack of significance could be due to the higher variance of 
percent inhibition between replications in the assays. The observation that calpastatin is a 
substrate for calpain (Mellgren et al., 1986; Doumit and Koohmarie, 1999) may contribute to 
this variation. 
m-calpain inhibition by calpastatin 
Inhibition of m-calpain by calpastatin was greater (P < 0.01) at pH 6.5 than 7.5 at 
both 165 and 295 mMNaCl (Table 4). Otsuka and Goll (1987) determined that calpastatin 
had a broad optimum pH, and concluded that inhibition of m-calpain by calpastatin was not 
affected by pH when casein was a substrate. Differences in results between these two studies 
could be due to differences in substrates used. As mentioned previously, the proteolytic 
susceptibility of the peptide used as a substrate in this study was not affected by pH or ionic 
strength, whereas pH may affect the solubility of casein used to determine calpain activity 
because the pi of casein is 4.6. In addition, the lowest ionic strength condition used in the 
current study was 165 mMNaCl. In the Otsuka and Goll (1987) study, the ionic strength 
conditions used were much lower. In the current study, inhibition of m-calpain was greater 
at 295 than at 165 mMNaCl at both 30 and 60 min and with the addition of both 0.15 and 0.3 
units of calpastatin. The high percent inhibition of m-calpain by calpastatin at the lower pH 
and higher ionic strength provides further evidence against a role for m-calpain in 
postmortem muscle. The observations made for p-calpain inhibition were different, in that 
(x-calpain inhibition was not as great as m-calpain inhibition at 295 mMNaCl and p-calpain 
was not affected by pH, indicating that p-calpain could be more active at conditions found in 
postmortem muscle. 
In early postmortem muscle, p-calpain inactivation, in response to either a rapid pH decline 
or by rapid autolysis, has the potential to decrease proteolysis of myofibrillar proteins and 
subsequent postmortem tenderization. Yet, intermediate pH decline allows for proteolytic 
activity of p-calpain, but a slower rate of autolysis could explain a portion of the variation in 
meat tenderness. A major role for m-calpain in postmortem proteolysis is not supported 
because the high ionic strength and low pH conditions, similar to conditions observed in 
postmortem muscle, appear to limit m-calpain activity. Additionally, the inhibition of p-
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calpain and m-calpain by calpastatin was greater at the higher ionic strength, indicating that 
calpastatin inhibits calpains to a greater extent in conditions similar to meat than in 
conditions found in living muscle. 
Implications 
Rate of pH decline in postmortem muscle has the potential to affect the rates of 
activation and subsequent autolytic inactivation of p-calpain. In addition, an increase in 
ionic strength in postmortem muscle may allow for more efficient inhibition of calpains by 
calpastatin. Therefore, rates of pH decline and increases in ionic strength are important 
variables to be considered when examining the variations in calpain-induced proteolysis of 
meat proteins in postmortem muscle. Studies centered on the question of how intracellular 
environmental factors affect p- and m-calpain will lead to a greater understanding of the role 
of calpain and calpastatin in the conversion of muscle to meat. 
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Table 1. Least squares means (± SE) of p-calpain activity at 30 and 60 min after addition of 
CaCl2 
Activity8 
165 mMNaCl 295 mMNaCl 
Treatment 30 min 60 min 30 min 60 min 
pH 7.5 
0 units calpastatin 94.21 ±2.50cx 152.53 ± 1.54cw 55.55 ±2.51dz 86.74 ± 1.54dy 
0.15 units calpastatin 62.67 ± 1.05dx 113.79 ±4.61dw 38.05 ± 1.96ez 58.40 ±4.61fy 
0.30 units calpastatin 44.99 ± 1.84= 79.83 ± 1.65ew 21.00 ±0.63fz 35.50 ± 1.658y 
pH 6.5 
0 units calpastatin 131.65 ±6.79by 208.18 ±8.87bw 100.62 ± 3.79bz 166.19 ±7.20bx 
0.15 units calpastatin 87.01 ± 5.69cy 146.95 ±7.51cw 69.19 ±6.03cz 114.12±7.11cx 
0.30 units calpastatin 60.44 ± 1.87dy 112.38 ±4.16dw 33.29 ±2.33= 72.59 ± 2.96" 
pH 6.0 
0 units calpastatin 46.47 ± 3.20ex 68.12 ±4.48^ 18.35 ± 1.63fz 27.79 ± 1.63hy 
0.15 units calpastatin 29.91 ±2.50fe 49.39 ± 2.79gw 12.28 ±0.92^ 19.54 ±0.92iy 
0.30 units calpastatin 24.08 ± 0.39^ 38.68 ±0.61hw 6.91 ± 1.34hz 12.30 ± 1.34jy 
^Activity = fluorescence units with CaClz - fluorescence units with EDTA (n = 3). 
b,c,d,e,f,g,h,ij Within a column, least squares means lacking a common superscript differ (P < 
0.01). 
w,x,y,z Within a row, least squares means lacking a common superscript differ (P < 0.05). 
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Table 2. Least squares means (± SE) of m-calpain activity taken at 30 and 60 min after 
addition of CaCli 
Activity3 
165 mMNaCl 295 mMNaCl 
Treatment 30 min 60 min 30 min 60 min 
pH 7.5 
0 units calpastatin 98.12 ± 2.98b* 120.74 ±6.85bw 15.95 ±0.50bz 19.63 ± 1.05by 
0.15 units calpastatin 72.92 ± 2.64"? 88.71 ±3.19= 8.87 ±0.14= 10.23 ± 0.23= 
0.30 units calpastatin 50.11 ± 1.01dy 61.32 ± 1.74dx 4.90 ± 0.64dz 5.07 ± 0.76dz 
pH 6.5 
0 units calpastatin 36.37 ± 0.52= 58.45 ±2.15dw 5.10 ± 0.25dz 7.66 ± 0.4 ley 
0.15 units calpastatin 22.92 ± 1.39fy 37.59 ±2.81= 1.97 ±0.24= 2.84 ± 0.06fz 
0.30 units calpastatin 10.56 ± 1.96^ 20.89 ± 1.66& 1.25 ± 0.08ey 1.85±0.07fy 
aActivity= fluorescence units with CaCfr fluorescence units with EDTA (n=3). 
b,c,d,e,f>g within a column, least squares means lacking a common superscript differ (P < 0.01). 
w
'
x,y,z Within a row, least squares means lacking a common superscript differ (P < 0.05). 
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Table 3. Least squares means (± SE) of percent inhibition of p-calpain by 0.15 and 0.3 units 
calpastatin3 calculated from p-calpain activity measured at 30 and 60 min after the addition 
ofCaCl2 
Percent inhibition 
165 mMNaCl 295 mMNaCl 
Treatment 30 min 60 min 30 min 60 min 
pH 7.5 
0.15 units calpastatin 33.48 ± 1.12
cy 25.39 ± 1.59cz 40.93 ± 3.53dy 32.67 ±5.31cz 
0.30 units calpastatin 52.25 ±1.96by 47.66 ±2.96bz 75.58 ± 1.14bw 58.98 ±1.91bx 
pH 6.5 
0.15 units calpastatin 33.90 ± 4.32cy 29.41 ±3.61cy 31.24 ±6.00cy 31.33 ±4.27cy 
0.30 units calpastatin 54.09 ± 1.42bx 46.02 ±2.00by 66.92 ± 2.32bw 56.32 ± 1.77bx 
pH 6.0 
0.15 units calpastatin 35.63 ±5.37=* 27.49 ±4.10^ 33.11 ±2.87^ 29.70 ±3.32^ 
0.30 units calpastatin 48.19 ±1.41bz 43.21 ±0.89bz 62.35 ±0.81bx 55.74 ±4.83by 
3 Inhibition was calculated as the percent inhibition = 1-(calpain activity without calpastatin + 
calpain activity with calpastatin; n=3). 
b,c Means in a column without a common superscript differ (P < 0.01). 
x,y,z Within a row, means without a common superscript differ (P < 0.05) 
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Table 4. Least squares means (± SE) of percent inhibition of m-calpain by 0.15 and 0.3 units 
calpastatin6 calculated from m-calpain activity at 30 and 60 min after the addition of CaCl% 
Percent inhibition 
165 mMNaCl 295 mMNaCl 
Treatment 30 min 60 min 30 min 60 min 
pH 7.5 
0.15 units calpastatin 25.68 ± 2.69= 26.53 ± 2.63= 44.36 ± 0.89ey 47.89 ± 1.17dx 
0.30 units calpastatin 48.92 ± 1.78fz 49.21 ± 1.44= 69.29 ± 4.07cy 74.17 ±3.88bx 
pH 6.5 
0.15 units calpastatin 36.98 ± 3.83= 35.70 ±4.81dz 61.37 ±4.65dy 62.92 ± 0.78cy 
0.30 units calpastatin 70.92 ± 5.36by 64.26 ± 2.83b' 75.49 ± 1.52bw 75.85 ±0.92bw 
a Inhibition was calculated as the percent inhibition = 1-(calpain activity without calpastatin 
calpain activity with calpastatin; n=3). 
b,e
'
,e Within a column, least squares means lacking a common superscript differ (P < 0.01). 
x,y,z Within a row, least squares means lacking a common superscript differ (P < 0.05). 
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Incubation time (min) 
pH 0 5 10 15 20 25 
7.5 
gBKBg c—BOkDa 
#### ##MN&  ^ 78kDa 
0 15.5±0.07b 32.6±1.20b 49.1±1.75b 65.3±2.13b 80.6±2.33b 
4MMÊWW& ggggt . 4—80 kDa 
76 kDa • UPP *;i# ##. aUft '= " " 78 kDa 
0 19.1±1.44a 43.9±3.60a 70.1±5.16a 92.8±6.19a 113.1±6.60a 
6 0 mm-mm mm mm ^«œ, 
76 kDa—• '####- #00# SRI 0000' 0000 •* 78 kDa 
0 10.4±0.78° 18.8±1.45c 27.1±2.02c 34.3±2.40c 40.8±2.78c 
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EFFECT OF OXIDATION, pH AND IONIC STRENGTH ON CALPASTATIN 
INHIBITION OF p- AND m-CALPAIN 
A paper submitted to the Journal of Animal Science 
K.R. Maddock, E. Huff-Lonergan, L.J. Rowe, and S.M. Lonergan* 
Abstract 
The objective of this study was to evaluate the effect of oxidation on p- and m-calpain 
activity at varying pH and ionic strength conditions in the presence of calpastatin. In two 
separate experiments, purified porcine skeletal muscle |> or m-calpain (0.45 units of 
caseinolytic activity) was incubated in the presence of calpastatin (0,0.15, or 0.30 units) at 
pH 7.5,6.5, or 6.0 with either 165 mM NaCl or 295 mM NaCl. The reactions were initiated 
wi th  add i t ion  o f  CaCla  (100  f - iM fo r  (a -ca lpa in ;  1  mM for  m-ca lpa in ) .  In  exper imen t  l , p -o r  
m-calpain were incubated with the calpain substrate Suc-Leu-Leu-Val-Tyr-AMC (170 \iM). 
Either 0 or 0.16 \xM H2O2 was added to each assay. Activity was measured at 60 min. In 
experiment 2, calpain was incubated with highly purified porcine myofibrils (4 mg/ml) under 
conditions described. Either 0 or 100 \iMH2O2 was added immediately prior to the addition 
of calpain. Degradation of desmin was determined on samples collected at 2,15, 60,120 
min. Calpain activity measured in experiment 1 indicated that that oxidation decreased (P < 
0.01) activity of ^-calpain. (i-Calpain had the greatest (P < 0.01) activity at pH 6.5 and m-
calpain had the greatest (P < 0.01) activity at pH 7.5 at 60 min. No activity of m-calpain was 
detected at pH 6.0. |i- and m-Calpain activity were lower {P < 0.01) at 295 mMNaCl than at 
165 mMNaCl at all pH conditions. Oxidation lowered (P < 0.01) calpastatin inhibition of |i-
and m-calpain at all pH and ionic strength combinations. In experiment 2, oxidation 
decreased proteolytic activity of p-calpain against desmin at pH 6.0 (P < 0.05 at 15, 60, and 
120 min) and m-calpain at all pH conditions. However, inhibition of g-calpain degradation of 
desmin by calpastatin was decreased by oxidation at pH 7.5 and 6.5 at both ionic strengths (P 
= 0.03 at 60 min). This is consistent with the results from the activity assays that indicated 
oxidation decreased percent inhibition of p-calpain by calpastatin. In conclusion, these 
studies provide evidence that oxidation influences calpain activity and inhibition of calpains 
by calpastatin differently under varying environmental conditions. The results suggest that, at 
the higher pH conditions used, calpastatin may limit the possibility of oxidation-induced 
inactivation of ^-calpain. 
Keywords: Calpain, calpastatin, ionic strength, oxidation, proteolysis, pH 
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Introduction 
The significant changes in muscle cellular environment that occur early postmortem 
are known to affect meat quality (Huff-Lonergan et al., 1996). One of the most pronounced 
changes is the pH decline from near neutrality in living muscle to approximately 5.6 in meat. 
Another change that occurs is the increase in ionic strength from an approximate equivalent 
of 165 mMNaCl in living muscle to approximately 295 mMNaCl in meat (Winger and 
Pope, 1980-81). ^-Calpain is a main factor in postmortem proteolysis of cytoskeletal 
proteins and subsequent tenderization of meat (Goll et al., 1992; Koohmaraie, 1992). 
Another calpain, m-calpain is also present in muscle, and its action in postmortem proteolysis 
and meat tenderization is highly debated (As reviewed by Geesink et al., 2000). Calpains are 
regulated by several factors including calcium concentration, pH, and the endogenous 
inhibitor, calpastatin. An increase in ionic strength has been shown to decrease |i-calpain 
activity by decreasing the stability of autolyzed ^-calpain (Li et al., 2004; Geesink and 
Koohmaraie, 2000). Another change that occurs during postmortem aging of meat is an 
increase in protein oxidation (Rowe et al., 2004a; Martinaud et al., 1997). Oxidation has 
been shown to decrease the ability of p-calpain to degrade its substrates (Rowe et al., 2004b; 
Guttmann and Johnson, 1998). Therefore the objective of this study was to determine the 
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extent to which oxidation influences calpain activity and calpain inhibition by calpastatin 
under pH and ionic strength conditions observed in early postmortem muscle. 
Materials and Methods 
Purification of calpastatin, //-calpain, and m-calpain. 
Calpastatin, ^-calpain, and m-calpain were purified from porcine skeletal muscle 
based on the procedures outlined by Thompson and Goll (2000) with minor modifications as 
described by Maddock et al. (2005). Porcine semimembranosus sample (2 kg) was taken 
from a market barrow approximately 25 min after exsanguination, prepared as previously 
described, and loaded on a Q-Sepharose Fast Flow (Amersham Biosciences, Piscataway, NJ) 
anion-exchange column. Porcine calpastatin, p-calpain, and m-calpain were eluted in three 
separate peaks off this column. 
Purification of calpastatin. Fractions containing calpastatin activity were pooled and further 
purified using methods described by Thompson and Goll (2000) with modifications taken 
from procedures of Geesink and Koohmaraie (1998) as described by Maddock et al. (2005). 
Purification was completed using successive chromatography over Phenyl Sepharose 6 Fast 
Flow (Amersham Biosciences, Piscataway, NJ), Blue Sepharose 6 Fast Flow (Amersham 
Biosciences, Piscataway, NJ), and EMD TMAE 650 S (EM Science, Gibbstown, NJ). 
Purified calpastatin consisted only of a 68 kDa band when analyzed by SDS-PAGE and had a 
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specific activity of 451 U/mg protein. One unit of activity of calpastatin was defined as the 
ability to inhibit one unit of m-calpain caseinolytic activity (Koohmaraie et al., 1995). 
Purification of //- and m-calpain. |a- and m-Calpain were purified according to the methods 
of Thompson and Goll (2000) with minor modifications as described by Maddock et al. 
(2005). Fractions from the Q-sepharose column containing ^-calpain activity were pooled 
and m-calpain activity were pooled. The ^-calpain was purified using successive 
chromatography over a Phenyl Sepharose 6 Fast Flow (Amersham Biosciences, Piscataway, 
NJ), Butyl Sepharose 4 Fast Flow (Amersham Biosciences, Piscataway, NJ), EMD TMAE 
650 S (EM Science, Gibbstown, NJ), and DEAE-TSK Toyopearl (Supelco, Bellefonte, PA). 
The purified ^-calpain had a specific activity of 71.3 U/mg protein. One unit of calpain was 
defined as the amount of calpain required to increase the absorbance at 278 nM of the 
supernatant by one unit in 1 h incubation at 25°C due to the release of trichloroacetic acid-
soluble polypeptides resulting from the digestion of casein (Koohmaraie, 1990). 
Fractions containing m-calpain activity were pooled and purified using successive 
chromatography over a Phenyl Sepharose 6 Fast Flow (Amersham Biosciences, Piscataway, 
NJ), Reactive Red 120 (Sigma, St. Louis, MO), and DEAE-TSK Toyopearl (Supleco, 
Bellefonte, PA). Purified m-calpain had a specific activity of 147 U/mg protein. The 
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purified ^-calpain, m-calpain, and calpastatin were stored in TEM with the addition of 1 mM 
sodium azide at 4°C. 
Calpain Activity Assays 
In order to ensure that pH, ionic strength, and H2O2 did not directly influence the 
peptide, assays were also conducted with the enzyme carboxypeptidase Y (Calbiochem, La 
Jolla, CA). Carboxypeptidase Y has a pH optimum of pH 5.5-6.5, stability up to pH 8.0, and 
Suc-Leu-Leu-Val-Tyr-7-amino-4-methyl coumarin is a substrate for this enzyme (Stennicke 
et al., 1994). In these assays, carboxypeptidase Y was added in place of p- or m-calpain at 
0.5 (il (0.0045 \xM final concentration). Comparison of activity measured in the assays at pH 
7.5, 6.5, and 6.0, ionic strength of 165 mMNaCl and 295 mMNaCl, and 0 pMor 0.16 \xM 
H2O2 was done to determine if these environmental conditions changed the susceptibility of 
the peptide to proteolysis. 
The technique used in this experiment is a sensitive activity assay using a calpain 
substrate, Suc-Leu-Leu-Val-Tyr-7-amino-4-methy 1 coumarin (Bachem; Torrence, CA; 10 
mg/ml in dimethyl sulfoxide), which is a known substrate of |> and m-calpain (Sasaki et al., 
1984). The highly purified calpains (p.- or m-calpain; 0.45 units caseinolytic activity) were 
incubated with 170 pM Suc-Leu-Leu-Val-Tyr-AMC in either the presence of highly purified 
calpastatin (0.15, or 0.30 units measured against 0.45 units of m-calpain caseinolytic activity) 
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or 0 units of calpastatin under the following conditions: 1) pH 7.5,165 mMNaCl 2) pH 7.5, 
295 mMNaCl 3) pH 6.5, 165 mMNaCl 4) pH 6.5,295 mMNaCl 5) pH 6.0,165 mMNaCl 
6) pH 6.0,295 mMNaCl. The buffers were either 50 mMHEPES (pH 7.5 and 6.5) or 50 
mM 2-(4-morpholino)-ethane sulfonic acid (MES) (pH 6.0). Oxidation treatments consisted 
of the addition 0.16 11MH2O2 immediately prior to addition of calpain. The reactions were 
initiated with the addition of 100 \xM CaCl? (^-calpain) or 1 mM CaCl2 (m-calpain). Calpain 
activity and percent inhibition by calpastatin (percent inhibition = 1-(calpain activity without 
calpastatin + calpain activity with calpastatin) x 100) were measured at 60 min in a TD-700 
fluorometer (Turner Designs, Sunnyvale, CA). A control with calcium (without the addition 
of |i- or m-calpain) for each pH and ionic strength condition was conducted to determine if 
calcium affected the fluorescence of the peptide. An EDTA control (20 mMEDTA final 
concentration added prior to addition of calpain and calcium) was included for each pH and 
ionic strength condition and used for the baseline. 
Myofibril Isolation 
Porcine semimembranosus (100 g; 45 min postmortem) was homogenized in ice cold 
extraction buffer (10 mMEDTA, 2 |xME-64, 100 mg/L trypsin inhibitor, and 2 mM 
phenylmethylsulfonylfluoride [PMSF], 100 mMTris-HCl, pH 8.3) using a polytron PT 3100 
(Kinmetica AG, Littau, Switzerland) set at 10,000 rpm. Samples were centrifuged (20,000 X 
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g) for 30 min at 4°C. Pellets were homogenized in 10 vol of standard salt solution (100 mM 
KC1, 2 mMMgCh, 1 mMEGTA, 1 mMNaNg, 20IÏ1MK2HPO4, pH 7.0). Purification of 
myofibrils was completed by differential centrifugation (Goll et al., 1974), and protein 
concentration was determined using the Biuret method as modified by Robson et al. (1968). 
Digest of myofibrils 
The highly purified calpains (0.45 units caseinolytic activity/ml in the assay) were 
incubated with highly purified porcine myofibrils in suspension (4 mg/ml buffer) in the 
presence of calpastatin (0.15, or 0.3 units measured against 0.45 units of m-calpain 
caseinolytic activity/ml in the assay) or 0 units calpastatin under the following conditions: pH 
7.5; 165 mMNaCl, 295 mMNaCl, pH 6.5; 165 mMNaCl, 295 mMNaCl, and pH 6.0; 165 
mMNaCl, 295 mMNaCl. The buffers were either 50 mMHEPES (pH 7.5 and 6.5) or 50 
mMMES (pH 6.0). Oxidation treatment consisted of the addition of 100 \xM H2O2 (Saurin et 
al., 2004). The reactions were initiated with the addition of CaCl2 at a final concentration of 
100 (xM(|x-calpain) or 1 mM (m-calpain). Aliquots were removed at 2,15, 60, and 120 min 
after the addition of calpain. The digests were terminated by the addition 20 mMEDTA 
(final concentration). The aliquots were centrifuged at 6000 x g for 15 min at 4°C. A 
portion of the pellet was used for SDS-PAGE and immunoblotting to determine changes in 
desmin. 
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SDS-PAGE and Western Blotting 
SDS-PAGE and membrane transfer were conducted as described by Rowe et al. 
(2004b) using 10% polyacrylamide separating gels and a desmin primary antibody 
(polyclonal rabbit anti-desmin antibody, V2022; Biomedia, Foster City, CA) for desmin. A 
sensitive chemiluminescent (ECL Plus kit; Amersham Biosciences, Piscataway, NJ) system 
was used to detect labeled protein bands using a charged coupled device (CCD) camera 
(FluroChem 8800; Alpha Innotech Corporation, San Leandro, CA) and FluorChem IS-800 
software (Alpha Innotech Corporation, San Leandro, CA). Densitometry was completed 
using the AlphaEaseFC software (Alpha Innotech Corporation, San Leandro, CA). A 
reference sample was used on each blot in order to standardize densitometry data to compare 
differences between blots. 
Oxidation of calpastatin 
Calpastatin (10 units) was incubated with an irreversible sulfhydryl blocking agent N-
ethylmaleimide (NEM; 0, 4, 8, or 12 mM final concentration; n=2) for 1 h at 4°C. Samples 
were exhaustively dialyzed in 1 mMEDTA, 40 mMTris-HCl, pH 7.5 to remove NEM. 
Activity of calpastatin after dialysis was determined by measuring inhibition of m-calpain 
caseinolytic activity (Koohmaraie et al., 1995). A protein assay (Bradford et al., 1976) was 
conducted on each sample to determine specific activity of each calpastatin sample. 
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Statistical Analysis 
Data were analyzed using a split-split plot design. The whole plot was pH/Ionic 
strength (7.5-165, 7.5-295, 6.5-165,6.5-295, 6.0-165, or 6.0-295). The split plot was 
calpastatin (0, 0.15, or 0.30 units). The split-split plot was H2O2 (0 or 0.16 jaM/100 \xM). 
Calpain activity at 60 min and densitometry of intact desmin was analyzed using PROC 
MIXED procedure in SAS (SAS Institute, Inc., Cary, NC). Least squares means were 
separated using Tukey's Honestly Significant Difference test. Significance was defined as P 
<0.05. 
Results 
Carboxypeptidase Y activity control 
Ionic strength, pH, or H2O2 conditions (Table 1) used in these experiments did not 
alter susceptibility of the peptide to proteolysis. Fluorescence measured at 60 min at pH 
7.5,165 mMNaCl and 0 \iM H2O2 was defined as 100 % of carboxypeptidase Y activity. It 
was concluded that the synthetic peptide was not affected {P > 0.5) by the differing pH, ionic 
strength, and oxidation conditions and was appropriate to use for our study. 
Calpastatin oxidation 
Irreversibly blocking sulfhydryls with NEM did not alter the specific activity of 
calpastatin. The specific activity of control calpastatin was 416 units of activity/mg protein. 
The mean specific activity of the oxidized calpastatin is 406.5,410.5, and 398 units of 
activity/mg protein for 4, 8, and 12 mMNEM respectively. 
Calpain Activity Assays 
fi-Calpain activity. Fluorescence measurements at 60 min indicate that the addition of H2O2 
significantly decreased (P < 0.05; Table 2) p-calpain activity regardless of pH and ionic 
strength conditions. ^-Calpain had greater activity at pH 6.5 (P < 0.01) than pH 7.5 or 6.0. 
p-Calpain activity was lower (P < 0.05) at 295 mMNaCl than at 165 mMNaCl. 
m-Calpain activity. Similar to ^.-calpain, addition of H2O2 significantly -decreased (P <0.01; 
Table 3) activity of m-calpain at all pH and ionic strength conditions. Furthermore, the 
presence of H2O2 in the assays completely prevented proteolytic activity of m-calpain at pH 
6.5 and 295 mMNaCl, with or without the presence of calpastatin. In contrast to g-calpain, 
m-calpain had greater activity at pH 7.5 (P < 0.01) than pH 6.5. Higher ionic strength 
decreased (P < 0.05) m-calpain activity. No measurable activity of m-calpain was detected at 
pH 6.0 which was previously observed by Maddock et al. (2005). 
fi-Calpain inhibition by calpastatin. Calpastatin inhibited (P < 0.05; Table 4) ^.-calpain 
activity at all pH and ionic strength conditions. Percent inhibition of |j.-calpain activity by 
calpastatin was not affected by pH (P > 0.05), but it is noteworthy that at pH 6.5 and 165 mM 
NaCl, only 12.77 % inhibition occurred when 0.15 units of calpastatin was added to the 
assay. This lower percent inhibition of ^-calpain activity by calpastatin was not observed 
when the higher ionic strength was used at pH 6.5. However, in the presence of H2O2 at pH 
7.5 and 295 mMNaCl, 0.15 units of calpastatin only inhibited 5.99% of p-calpain activity. 
Higher ionic strength increased (P < 0.05) percent inhibition of ^-calpain activity by 
calpastatin at pH 6.5 and 6.0, but not at pH 7.5. The addition of H2O2 not only caused a 
decrease in activity of p-calpain, as discussed previously, but also caused a decrease (P < 
0.05) in the percent inhibition of ^-calpain activity by calpastatin at pH 7.5 and 6.5 at both 
ionic strengths and at pH 6.0 and 295 mMNaCl. The effect (P > 0.05) of oxidation was not 
significant at pH 6.0 and 165 mMNaCl. 
m-Calpain inhibition by calpastatin. Calpastatin inhibited (P < 0.05; Table 5) m-calpain 
activity at all pH and ionic strength conditions. There was no main effect (P > 0.05) of pH 
on percent inhibition of m-calpain by calpastatin. Inhibition percent was not reported at pH 
6.5 and 295 mMNaCl because no m-calpain activity was detected, even when 0 units of 
calpastatin was added to the assay. An ionic strength effect (P < 0.05) was observed where 
at 295 mMNaCl, percent inhibition of m-calpain by calpastatin was greater than at 165 mM 
NaCl, with the exception of assays conducted at pH 7.5 and 0.3 units of calpastatin. 
Interestingly, the same effect of H2O2 causing a decrease (P < 0.05) in percent inhibition of 
m-calpain by calpastatin was observed with m-calpain that was observed for ^-calpain. This 
effect was observed at pH 7.5 and 165 mMNaCl at both calpastatin levels and pH 7.5 and 
295 mMNaCl when 0.15 units of calpastatin was present. 
Digest of Myofibrils and Western Blots of Desmin degradation 
fi-Calpain myofibril digests. Differences in desmin degradation due to oxidation and 
calpastatin are observed. At pH 6.0, calpastatin decreased degradation of desmin as indicated 
by detection of intact desmin at 60 min and 120 min incubation with increasing levels of 
calpastatin at both 165 mMNaCl and 295 mMNaCl. An effect of oxidation was observed 
where the addition of H2O2 to the digest decreased the degradation of desmin, particularly 
obvious at 295 mMNaCl when 0 units of calpastatin were added to the digests and intact 
desmin is detected at all time points. 
The combination of calpastatin and H2O2 appear to work synergistically to limit the 
activity of p,-calpain at pH 6.0. The inhibition of fx-calpain by calpastatin was very different 
at pH 6.5 and 7.5. The addition of H2O2 appears to decrease the degradation of desmin under 
the conditions when 0 units of calpastatin were added to the digests. This is apparent at both 
pH and ionic strength conditions and is consistent with assays with the calpain substrate. 
Unexpected results occurred when calpastatin was added to the digests. These results are 
best evaluated when observing the blots from the pH 6.5 and 165 mMNaCl digests. It 
appears that the addition of H2O2 in the presence of calpastatin results in greater degradation 
of intact desmin. When H2O2 is added to the digests in the presence of 0 units of calpastatin, 
intact desmin is detected as late as 120 min incubation. When 0.15 units of calpastatin were 
added, the degradation of intact desmin is almost complete by 60 min as indicated by the 
very light band. Finally, when 0.3 units of calpastatin were added to the assay, degradation 
of intact desmin appears to be almost complete by 15 min. A similar pattern is observed at 
295 mMNaCl and at pH 7.5 at both ionic strength conditions. These effects are similar to 
the results observed in the calpain assays where percent inhibition of ^-calpain was 
decreased in the presence of H2O2. 
Densitometry data describing intact desmin degradation (n=2) are shown in Table 6 
and statistical main effects and interactions are shown in Table 7. After 2 min incubation, no 
significant main effects are observed. There is a trend toward an effect of pH (P = 0.08) 
where, at pH 6.5, degradation of desmin is less than pH 7.5 and 6.0 at all three levels of 
calpastatin. After 15 min incubation, an effect of oxidation (P = 0.04) is observed. The 
addition of H2O2, in general, causes a decrease in the degradation of desmin, as indicated by 
higher densitometry measurements. At 60 min incubation, many effects (P < 0.05) are 
observed. Oxidation decreased (P < 0.001) desmin degradation as indicated by more intact 
desmin. The interactions of pH x oxidation, calpastatin x oxidation, and pH x calpastatin x 
oxidation are significant. At pH 6.0 the combination of H2O2 and calpastatin appeared to be 
additive in its inhibitory effects on p-calpain activity versus pH 7.5 and 6.5 where the 
combination appeared to decrease inhibition. After 120 min incubation, many of the 
significant effects observed at 60 min are not apparent. This is due to the almost complete 
degradation of intact desmin that occurs by 60 minutes under the different environmental 
conditions. An effect of oxidation (P - 0.04) is still observed, where in general, the presence 
of H2O2 decreased degradation of desmin by ^-calpain. 
m-Calpain myofibril digests. Visual analysis of western blots for desmin from the myofibril 
digests with m-calpain showed greater proteolysis of intact desmin at pH 7.5 than 6.5, and 
less proteolysis at 295 mMNaCl than 165 mMNaCl. More intact desmin was observed 
when calpastatin and H2O2 were present. In these samples, the addition of calpastatin and 
H2O2 appear to be additive in the inhibitory effect on m-calpain at pH 6.5 and 7.5. 
Densitometry data describing intact desmin degradation are shown in Table 8 (n=2) 
and main effects and interactions are shown in Table 9. After 15 min incubation, the pH x 
calpastatin interaction (P = 0.013) indicated there was more degradation of desmin at pH 7.5 
and 0 units calpastatin than at 0.15 units and 0.3 units calpastatin at pH 7.5 and at all levels of 
calpastatin at pH 6.5. By 60 min incubation, a main effect of calpastatin (P = 0.002) appears 
indicating calpastatin is inhibiting degradation of intact desmin by m-calpain. An interaction 
of pH x calpastatin (P < 0.001) occurs because adding more calpastatin decreased desmin 
113 
degradation at pH 7.5 but not at pH 6.5. A main effect of oxidation does not appear in the 
analysis of densitometry measurements, but there is an interaction of pH x oxidation (P < 
0.001) and calpastatin x oxidation (P = 0.005) results in the pH x calpastatin x oxidation 
interaction (P = 0.002), where at pH 7.5, the addition of H2O2 inhibited desmin degradation 
when 0 units of calpastatin was added at both ionic strength conditions and at pH 6.5, there is 
not a significant effect of oxidation. The ionic strength x calpastatin interaction (P = 0.013) 
indicates that calpastatin was a better inhibitor of desmin degradation by m-calpain at 295 
mMNaCl than at 165 mMNaCl, which is consistent with the results observed in the 
fluorescent assays (Table 5). By 120 min incubation, there is a reduction of the significance 
of the particular main effects and interactions observed at 60 min. 
Discussion 
During the conversion of muscle to meat, many changes occur within the 
environment of the muscle (Winger and Pope, 1980-81). Loss of homeostasis and depleted 
oxygen ultimately allow for these changes that include a pH decline from near neutrality to 
approximately 5.6 and a continued increase in ionic strength. These changes, when 
combined with the temperature decrease that occurs during harvest, can affect other 
postmortem processes that affect meat quality. These specific environmental changes have 
been shown to affect activity of calpains (Huff-Lonergan et al., 1996; Kendall et al., 1993). 
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Another change in environment that occurs with the loss of homeostasis is an increase in 
oxidative conditions (Martinaud et al., 1997; Harris et al., 2001). Oxidation can also affect 
calpain activity. A study by Guttman et al. (1997) evaluated (i-calpain activity when exposed 
to H2O2 and observed that proteolytic activity of jn-calpain was strongly inhibited. Rowe et 
al. (2004a) used irradiation to demonstrate that inactivation of ^-calpain resulted in a 
decrease in postmortem proteolysis and decrease in tenderization. Based on these 
observations, it is important to understand how environmental conditions of pH, ionic 
strength, and oxidation interact to affect calpain activity and additionally how the presence of 
calpastatin adds to these effects. 
In the current study, the objective was to determine the extent to which oxidation 
influences n- and m-calpain activity and calpain inhibition by calpastatin under the pH and 
ionic strength conditions observed in early postmortem muscle. Two different methods were 
used to evaluate the sum of the effects of pH, ionic strength, and oxidation of (i- and m-
calpain activity in the presence or absence of calpastatin. The first method used a calpain 
substrate in order to precisely measure activity of p.- and m-calpain and their inhibition by 
calpastatin. The second method used purified myofibrils as a substrate and evaluation of 
degradation of the protein desmin. This allowed definition of the effects of environment on 
the activities of p- and m-calpain and their inhibition by calpastatin using a substrate found in 
meat. It was concluded that both the calpain activity and inhibition of calpain by calpastatin 
can be dramatically affected by pH, ionic strength, and oxidation. The effects of 
environment were profoundly different between p- and m-calpain. 
pH and Ionic strength 
A previous study was conducted using the calpain substrate to evaluate p- and m-
calpain activity in the presence of reducing agents (Maddock et al., 2005). Ionic strength and 
pH effects similar to calpain activity assay results in the current study were observed on the 
activities of m- and ^-calpain and their inhibition by calpastatin. As observed in this study, 
m-calpain activity was also greatest at pH 7.5, and activity was least at pH 6.0. Additionally 
(4,-calpain activity was also greater at pH 6.5 versus 7.5 or 6.0. Western blotting of ^-calpain 
autolysis revealed that autolysis occurred at a slower rate at pH 6.5 than at 7.5. It was 
hypothesized that the observed activity differences were not due to a faster activation of (o,-
calpain, but rather a slower autolytic inactivation of p-calpain at pH 6.5. The ionic strength 
effects observed in Maddock et al. (2005) and the current study indicate that both p- and m-
calpain activities are decreased with increasing ionic strength. Geesink and Koohmaraie 
(2000) observed that ^-calpain activity decreased with increasing ionic strengths and 
indicated that the decrease in activity of p-calpain is due to a decrease in the stability of the 
molecule. Li et al. (2004) hypothesized that an elevated ionic strength (equal to 100 mM 
KCl) caused disassociation of the two calpain subunits, allowing for formation of dimers and 
timers of the large subunit, which irreversibly inactivated the proteinase. These results 
indicate that pH and ionic strength have the potential to affect activity of \x- and m-calpain 
through autolytic inactivation and dissociation. 
In the current study, inhibition of p-calpain and m-calpain by calpastatin were not 
affected by pH. This is consistent with reports by Geesink and Koohmaraie (1999) and 
Otsuka and Goll (1987). Calpastatin is the endogenous inhibitor of |> and m-calpain and 
does not inhibit any other protease that it has been tested against (Goll et al., 2003). The 
presence of Ca2+ is required for calpastatin to bind to the calpains in order to inhibit their 
activity (Cottin et al., 1981). In porcine muscle, the ratio of calpastatin activity to p-calpain 
activity is approximately 1.5:1 (Ouali and Talmant, 1990). The ratio of calpastatin to calpain 
used in this study was 1:3 and 2:3 in order to evaluate the effect of calpastatin on calpain 
without the occurrence of complete inhibition. Maddock et al. (2005) reported an effect of 
pH on inhibition of m-calpain was observed where inhibition was greater at pH 6.5 than 7.5. 
The discrepancy between this study and the previous study is likely due to the presence of a 
reducing agent in Maddock et al. (2005) when the activity of m-calpain was maximized, 
where in this study no reducing agents were used in order to maximize the effect of oxidation 
on activity and inhibition. 
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Oxidation 
Since p- and m-calpain are cysteine proteases, their activity requires the exchange of 
electrons between the active site cysteine and histidine residues (Mehdi, 1991). The cysteine 
residue site is highly susceptible to oxidation by H2O2 (Neumann, 1972). Oxidation of 
calpain with H2O2 can allow for inactivation of calpain (Guttmann et al., 1997) indicating 
that the active site cysteine residue may be oxidized. Oxidation decreased the proteolytic 
activity of |i-and m-calpain (Table 2 and Table 3) in the activity assays. When using 
myofibrils as a substrate, the main effect of oxidation (Table 7) was specifically noted on jj,-
calpain. The effect of oxidation on m-calpain (Table 9) in this system was detected only 
when also considering interactions with pH and ionic strength in combination with 
calpastatin. Previous studies observed similar effects of oxidation on p-calpain activity in 
meat (Rowe et al., 2004a) and in vitro (Guttmann et al., 1997; Guttmann and Johnson, 1998). 
Evidence that cysteine residues on calpastatin are not affected by oxidation is 
provided in this study by incubations with NEM, which covalently blocks sulfhydryl groups, 
resulting in effects similar to oxidation. This important observation provides evidence that 
oxidation of calpastatin does not affect its action on inhibition of calpains. 
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Effect of treatment combinations 
Many of the singular effects of environment did not appear be significant on p- or m-
calpain activity. However, the specific objectives of these experiments were to evaluate the 
interactions between environmental conditions. The interaction of oxidation and calpastatin 
indicates that these environmental combinations do have an effect on the proteolytic activity 
of |i- and m-calpain, therefore having implications in postmortem muscle and also in living 
muscle tissue. 
The presence of H2O2 decreased the percent inhibition of both jx- and m-calpain by 
calpastatin when using the calpain substrate. This corresponds to the effects observed in the 
p-calpain degraded myofibrils where the addition of H2O2 in the presence of calpastatin 
allowed for greater degradation of desmin at the higher pH of 7.5 and 6.5. These 
observations were unique to ^-calpain in the digests of myofibrils. 
The role of calpastatin in binding to and inhibiting calpain is an area of research that 
is currently getting some attention as the exact mechanism is not understood (Goll et al., 
2003). As previously discussed, Ca2+ is required for binding of calpastatin to calpains 
(Cottin et al., 1981). The Ca2+ concentration required for binding of calpastatin to p- and m-
calpain is lower than the Ca2+ concentration required for proteolytic activity at half-maximal 
rate. This indicates that, if present, calpastatin will bind and inhibit calpain before it can 
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become proteolytically active (Kapprell and Goll, 1989). Calpastatin is considered a 
competitive inhibitor of calpains based on kinetic evidence (Croall and McGrody, 1994). 
However, evidence indicates that calpastatin does not bind at the active site of calpain 
(Nishimura and Goll, 1991, Croall and McGrody, 1994), but rather near the active site in a 
way that blocks access of substrates as hypothesized by Todd et al. (2003). In the current 
study, when calpastatin/^-calpain complex was formed, and then exposed to H2O2, greater 
degradation of desmin was observed at pH 6.5 and 7.5. Oxidation of the active site cysteine 
residue decreases calpain activity (Guttmann et al., 1997). It is possible that the interaction 
of calpastatin with p-calpain occurs in a way that blocks H2O2 from accessing and oxidizing 
the active site cysteine residue, thus preventing oxidative inactivation of p-calpain. Doumit 
and Koohmaraie (1999) observed that calpastatin is also as substrate for calpains in addition 
to its role as an inhibitor. If calpastatin is preventing oxidation of the p-calpain cysteine 
residue, it may be possible for activated calpain to degrade calpastatin present, particularly at 
the levels used in these assays, and allow for greater proteolytic activity to occur. 
The significant interaction of pH x oxidation on desmin degradation for both jli- and 
m-calpain are different for the two proteinases. Oxidation decreased desmin degradation by 
|i-calpain at pH 6.5 to a greater extent than at pH 7.5 and 6.0. Oxidation decreased desmin 
degradation by m-calpain to a greater extent at pH 7.5 than pH 6.5. (i-Calpain was most 
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active at pH 6.5 and m-calpain was most active at pH 7.5. Oxidation appears to have a 
greater affect when each calpain was in the environment where it was most active. The 
oxidized calpain activity observed may be the maximum activity attainable, regardless of pH 
conditions. When calpastatin was included, an interaction of pH x calpastatin x oxidation 
was observed for both calpains. In the |>calpain myofibril digests, when calpastatin levels 
increased from 0.15 units to 0.3 units, the addition of H2O2 allowed for greater desmin 
degradation. When m-calpain was the proteinase used in the assays, the addition of 
calpastatin decreased degradation of desmin, but this decrease in degradation was larger at 
pH 7.5 than 6.5. |i- and m-Calpain are very similar in structure as they consist of an identical 
small subunit and a large subunit with 55-65% homology (Suzuki, 1991). The large subunit 
is where the active site is located. The observed differences in pH are likely due to the 
variation between the two calpain structures and the differences in how calpastatin interacts 
with these molecules at the varying pH conditions. 
The interaction of ionic strength x oxidation was significant for ^-calpain degradation 
of desmin, but this interaction was not significant for m-calpain. In general, the higher ionic 
strength decreased the oxidation effects on p-calpain activity and allowed for greater 
degradation of desmin particularly when calpastatin was added to the assays, which explains 
the significant interaction of ionic strength x calpastatin x oxidation. When calpastatin was 
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included in the interaction analysis, the ionic strength x calpastatin x oxidation interaction 
was significant with m-calpain but at higher ionic strength, desmin degradation decreased 
with oxidation in the presence of calpastatin. 
When all four environmental factors were evaluated, the interaction of these factors 
did not significantly affect p-calpain activity. There was a significant interaction of all four 
factors on m-calpain. To explain this, m-calpain was more active at pH 7.5 than 6.5 and at 
165 mMNaCl than at 295 mMNaCl. Calpastatin inhibited m-calpain to a greater extent at 
pH 7.5 than 6.5, and the addition of H2O2 decreased desmin degradation to a greater extent at 
the higher ionic strength. 
The results of this study indicate that (i-calpain and m-calpain react differently to 
different environments. Interestingly, the environmental conditions that are observed in 
postmortem muscle are the conditions that appear to be most favorable to activation of p-
calpain. This is consistent with previous hypotheses (as reviewed by Geesink et al., 2000) 
that indicate (a-calpain and not m-calpain is responsible for the proteolysis that occurs in 
postmortem muscle and therefore subsequent tenderization. 
The effects of oxidation observed in this study have implications in meat quality. Rowe at al. 
(2004a) evaluated how oxidative conditions initiated by irradiation early postmortem caused 
inhibition of p,-calpain activity slowing the rate of proteolysis occurring during aging, 
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thereby decreased tenderization. Antioxidants are currently becoming more prevalently used 
in the meat industry to increase shelf life by preventing oxidation of lipids that cause 
rancidity. Previous research has also evaluated the use of antioxidants as a feed supplement 
and how their use can affect meat tenderization. Harris et al. (2001) evaluated increased 
levels of alpha-tocopherol in beef through supplemental vitamin E in the diet in combination 
with injecting steaks with CaCl?. They found that beef with increased levels of alpha-
tocopherol exhibited a faster rate of decline of Warner-Bratzler Shear Force values and a 
faster rate of troponin-T degradation. Additionally, Rowe at al. (2004a) observed an increase 
in the rate of troponin-T degradation in beef from calves fed a diet supplemented with 
vitamin E. 
Oxidation has been shown to decrease activity of calpains, but in contrast, calpains 
have also been shown to play a role in protein degradation when oxidative conditions are 
higher than normal. A relationship between protein oxidation and proteolysis has been 
clearly established (as reviewed by Mehlhase and Grune, 2002) where it has been established 
that oxidation of proteins can enhance susceptibility to proteolytic degradation, but at the 
same time, the excessive oxidation may cause a decrease in susceptibility to degradation. 
Oxidative stress, in combination with observed intracellular Ca2+ concentration in a mouse 
embryonal carcinoma cell line (Ray et al., 2000) and a rat adrenal gland cell line (Ishihara et 
al., 2000) have shown an increase in activation of calpains. Pronzato et al. (1993) observed 
the level of oxidative stress can affect calpain activity, where moderate levels of oxidation 
enhance activity but increased oxidative exposure can cause inactivation of calpains. These 
observations could provide an explanation of how the involvement of calpastatin regulates 
oxidation of g-calpain and allow activation to occur. 
In summary, activity differences were observed due to pH where ^-calpain had 
greater activity at pH 6.5 than pH 7.5, while the opposite was true for m-calpain. Oxidation 
of m-calpain with H2O2 resulted in a decrease of proteolytic activity and the addition of 
calpastatin decreased proteolytic activity even further as demonstrated by the decrease in 
desmin degradation (Figure 2). Oxidation of p-calpain with H2O2 did decrease proteolytic 
activity, but oxidation of the calpastatin/^-calpain complex with H2O2 resulted in increased 
proteolysis of desmin (Figure 1) and therefore appeared to increase activity of ^-calpain in 
the presence of H2O2. This novel observation is important, because it demonstrates that 
inhibition of ^-calpain by calpastatin is diminished by oxidation. 
Implications 
Oxidative conditions in postmortem muscle could have an effect on proteolytic 
activity that occurs during the aging process. The differences observed between oxidation of 
p-calpain versus m-calpain provide further evidence of the role of g-calpain in postmortem 
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proteolysis. The results from may also explain some of the variation observed in tenderness, 
as the interactions of pH, ionic strength, and oxidation in addition to the presence of 
calpastatin cause p-calpain to act differently than if examined under each environmental 
factor alone. These results also indicate a need for greater understanding of the interaction of 
calpastatin with the calpains in order to understand how these proteins function in the 
muscle. 
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Table 1. Carboxypeptidase Y control activity 
Percentage is based on measurements taken after 60 min at pH 7.5 and 
165 mM NaCl and no H2O2 added is 100 % 
Percent Activity 
165 mMNaCl 295 mMNaCl 
PH Con H2O2 Con H2O2 
7.5 100 95.9 106 102 
6.5 99.3 102 92.1 92.7 
6.0 96.4 95.6 93.4 98.1 
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Table 2. Least squares mean (± SE) of (i-calpain activity at 60 min after addition of CaCl? 
Activity 
165 mMNaCl 295 mMNaCl 
Treatment 
Con H202 Con H2O2 
7.5 
0 63.99 ± 0.69dw 36.73 ± 2.48cy 40.77 ± 1.5 lbx 13.81 ±0.69" 
0.15 50.16 ±0.66ex 32.15 ±4.19cy 33.18 ±0.88cy 12.98 ± 0.85= 
0.30 35.22 ±2.13& 22.98 ± 4.42dy 20.67 ± 1.21ey 9.14 ± 1.65dez 
6.5 
0 117.72 ±5.02aw 50.07 ± 1.98ay 58.99 ± 1.54ax 25.44 ± 1.61" 
0.15 102.68 ± 1.43bw 43.72 ± 1.97bx 39.86 ± 1.79by 19.24 ± 1.36bz 
0.30 78.12 ±3.74cw 36.23 ± 0.46* 26.41 ±0.67dy 13.83 ±0.36cz 
6.0 
0 11.85 ±0.17gy 6.45 ± 0.36= 18.25 ± 1.26ex 11.48 ± 0.85cy 
0.15 8.94 ± 0.54hy 4.54 ± 1.10fz 12.31 ±0.28fx 8.59 ± 0.1 ldy 
0.30 7.97 ± 0.28 ix 4.59 ±0.36* 8.48 ± 0.49gx 7.66 ± 0.39" 
0.05; n=3) 
w,x,y,z Within a row, least squares means lacking a common superscript differ (P < 0.05). 
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Table 3. Least squares means (± SE) of m-calpain activity at 60 min after addition of CaCla 
Activity 
165 mMNaCl 295 mMNaCl 
Treatment Con H2O2 Con H2O2 
7.5 
0 93.14 ±7.15" 23.59 ±2.37" 53.83 ± 1.41* 26.44 ±1.19" 
0.15 46.34 ± 1.86bx 15.06 ± 1.17bz 21.52 ±0.54by 16.21 ±0.21bz 
0.30 21.38 ± 1.90™ 7.92 ± 1,00cz 11.83 ± 0.56cy 6.92 ± 0.76cz 
6.5 
0 18.00 ±0.41dx 7.82 ± 0.81cy 6.34 ± 2.10dy ND^ 
0.15 8.27 ± 0.33™ 2.95 ± 1.54dy 1.34 ± 0.47ey NDdz 
0.30 6.24 ± 0.40fx 2.92 ± 0.17dy 0.09 ± 0.19fz NDdz 
n=3) 
w,x,y,z Within a row, least squares means lacking a common superscript differ (P < 
0.05).Value in parentheses - standard error of the mean 
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Table 4. Least squares means (± SE) of percent inhibition of p-calpain by 0.15 and 0.3 units 
calpastatin3 calculated from fluorescence measurements taken at 60 min after the addition of 
CaCl2 
Percent Inhibition 
165 mMNaCl 295 mMNaCl 
Treatment Con H2O2 Con H2O2 
7.5 
0.15 
0.30 
21.61 ±2.16dx 
44.96 ± 2.95% 
12.47 ±6.19byz 
37.44 ± 6.95bz 
18.62 ± 2.16exy 
49.29 ± 2.95by 
5.99 ±6.18= 
33.83 ± 6.95= 
6.5 
0.15 12.77 ± 1.21ex 12.67 ± 3.93bx 32.44 ± 3.04cy 24.37 ±5.38dx 
0.30 33.64 ±3.18™ 27.63 ± 0.93bx 55.23 ± 1.15bz 45.65 ± 1.42% 
6.0 
0.15 24.54 ± 4.62dz 29.56 ± 15.70bcyz 32.53 ± 1.51cy 25.19 ±0.94dz 
0.30 32.69 ±2.39™ 28.73 ± 5.55bx 53.52 ±2.66by 33.29 ±3.35™ 
a Inhibition was calculated as the percent inhibition = (1-(calpain activity without calpastatin 
-i- calpain activity with calpastatin)) xlOO (n=3). 
b,c Within a column, least squares means lacking a common superscript differ (P < 0.05; n=3) 
x,y,z Within a row, least squares means lacking a common superscript differ (P < 0.05). 
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Table 5. Least squares mean (±SE) of percent inhibition of m-calpain by 0.15 and 0.3 units 
calpastatin3 calculated from fluorescence measurements taken at 60 min after the addition of 
CaCl2 
Percent Inhibition 
165 mMNaCl 295 mMNaCl 
Treatment Con H2O2 Con H202 
7.5 
0.15 50.24 ±2.01dx 36.15 ±4.96= 60.01 ± 1.01dw 38.68 ±0.81= 
0.30 
77.05 ± 2.04"* 66.41 ±4.23% 78.03 ± 3.04= 73.84 ±2.13bx 
6.5 
0.15 
54.07 ± 1.84dx 62.23 ± 19.71% 78.94 ± 7.44= 
0.30 
65.35 ± 2.25cy 62.74 ± 2.22% 98.53 ± 3.02bz 
3 Inhibition was calculated as the percent inhibition = (1-(calpain activity without calpastatin 
calpain activity with calpastatin)xl00 (n=3). 
b,c Within a column, least squares means lacking a common superscript differ (P < 0.05; n=3) 
x,y
'
z Within a row, least squares means lacking a common superscript differ (P < 0.05). 
Table 6. Relative intensity (±SE) of intact desmin after incubation with p-calpain (n=2). 
Time x Oxidation x ionic strength 
165 mMNaCl 295 mM NaCl 
Con h2o2 Con H2O2 
pH x calpastatin 2 min 15 min 60 120 2 min 15 60 120 2 min 15 min 60 120 2 min 15 min 60 min 120 
min min min min min min min min 
pH 7.5 
0 units 0.73 0.21 ^  0Z 0Z 0.57 toy 0.48 0.10abz 0.07* 0.75 ^  0.50"* 0.09" 0bs 0.77" 0.64** 0.43 0.38 
calpastatin «be? ±0.10 ±0.25 
abxy ±0.10 ±0.07 ±0.05 ±0.20 ±0.09 ±0.03 ±0.13 abyz abxyz 
±0.20 ±0.30 ±0.26 ±0.38 
0.15 units 0.72 0.41 0Z 0Z 0.91 ^  0.70ay 0.16bz 0i5abyz 0.67x 0.40 ^ 0te 0bz 0.70* 0.53 * 0.23 0" 
calpastatin 
abcyz ±0.66 ±0.10 ±0.06 ±0.15 ±0.07 ±0.12 ±0.17 0.02 bcyz 
±0.63 ±0.38 ±0.18 
0.3 units 0.87 0.43* 0Z 0Z 0.73 0.68 0.27 byz 0.12* 0.90 s 102" 0.84" 0.73"" 1.11* 0J8* 0.16 0.04" 
calpastatin 
abcx ±0.09 abcxy abxy ±0.19 ±0.12 ±0.06 ±0.12 ±0.09 ±0.21 ±0.44 ±0.13 h*
Z 
±0.04 
±0.17 ±0.38 ±0.28 ±0.16 
pH 6.5 
0 units 1.27aby 0.61"? 0Z 0Z 134™ 1.25" 0.89 0.76 1.11 0.63 0bz 0bz 0.94 0.71 0.36 0.27abz 
calpastatin ±0.45 ±0.05 ±0.36 ±0.51 axyz azxyz 
xyz dm*. abxyz abedxyz abcyz ±0.27 
±0.36 ±0.65 ±0.65 ±0.56 ±0.52 ±0.57 ±0.29 
0.15 units 1.13" 0.45 0Z 0Z 0.91 0.78" 0.59" 0.30bxy 0.99 0.53 0.03" 0te 1.16" 0.83 " 032* 0.14abyz 
calpastatin ±0.08 ±0.02 ±0.10 ±0.30 
TO ±0.03 ±0.18 ±0.03 ±0.09 ±0.14 
±0.23 ±0.24 ±0.57 ±0.49 
0.3 units 1.36™ 1.11av™ 0.06* 0.05" 1.33abv 1.03 0.32** 015* 0.70" 0.19* 0bz 0bz 0.59*" 0.44 ^ 0.05* 0.01bz 
calpastatin ±0.47 ±0.46 ±0.06 ±0.05 ±0.56 abv» ±0.16 ±0.03 ±0.05 ±0.11 ±0.23 ±0.04 ±0.05 ±0.01 
±0.50 
pH 6.0 
0 units 0 79 ta» 0.54 0.02z 0Z 0.60 e* 0.41" 0a 0ta 0.71" 028* Qta 0bz 0.92™ 0.65" 0.17 0.21abyz 
calpastatin ±0.04 ±0.06 ±0.02 ±0.09 ±0.13 ±0.12 ±0.11 ±0.11 ±0.04 
bcyz ±0.21 
±0.17 
0.15 units 0.71" 0.60*» 0.04z Oz 0.80*= 0.83 ^  0.75*9 0.68 ^ 0.78* 0.63** 0.07" 0.02" 0.72"? 0.72aby 0 58* 0.45 * 
calpastatin ±0.07 ±0.09 ±0.04 ±0.11 ±0.01 ±0.10 ±0.51 ±0.14 ±0.19 ±0.07 ±0.02 ±0.12 ±0.09 ±0.11 ±0.27 
0.3 units 0.90 "h™ 0.72 0.45 038*^ 0.89 bw 0.78" 0.5532 0.41 0.72 s 039*= 0.35 0.41 0.63 0.53 ^  039 ate 0.27" 
calpastatin ±0.06 awxyz ±0.38 ±0.07 ±0.02 ±0.10 ±0.28 ±0.03 ±0.28 abyz abxyz bxyz ±0.21 ±0.28 ±0.24 
±0.12 ±0.45 ±0.35 ±0.41 ±0.15 
Within a column, least squares means lacking a common superscript differ (P < 0.05) 
v,w,x
'
y,z Within a row, least squares means lacking a common superscript differ (P < 0.05) 
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Table 7. f-values of main effects and interactions of environmental conditions on ^-calpain 
degradation of desmin 
Treatment effects 2 min 15 min 60 min 120 min 
PH 0.08 0.45 0.78 0.74 
Ionic strength 0.44 0.48 0.97 0.92 
Calpastatin 0.94 0.48 0.41 0.58 
Oxidation 0.77 0.04 0.001 0.04 
pH x Ionic strength 0.18 0.46 0.80 0.89 
pH x calpastatin 0.36 0.61 0.23 0.33 
pH x oxidation 0.35 0.22 0.02 0.21 
Ionic strength x calpastatin 0.72 0.52 0.87 0.88 
Ionic strength x oxidation 0.79 0.15 0.008 0.13 
Calpastatin x oxidation 0.99 0.24 0.007 0.05 
pH x Ionic strength x calpastatin 0.29 0.32 0.66 0.71 
pH x Ionic strength x oxidation 0.66 0.24 0.07 0.48 
pH x calpastatin x oxidation 0.91 0.56 0.03 0.12 
Ionic strength x calpastatin x oxidation 0.98 0.42 0.06 0.17 
pH x ionic strength x calpastatin x oxidation 0.89 0.31 0.19 0.36 
Table 8. Relative intensity (±SE) of intact desmin after incubation with m-calpain (n=2). 
Time x Oxidation x ionic strength 
165 mMNaCl 295 mM NaCl 
Con H2O2 Con H2O2 
pHx 2 min 15 60 120 2 15 60 120 2 15 60 120 2 15 60 120 
calpastatin min min min min min min min min min min min min min min min 
pH 7.5 
0 units 0.93*" 0.55** 0= 0Z 0.91" 0.95*" 0.59bcx 0.14 = 1.01" 0.87™ 0bz obz 0.92*" 0.87™ 0.39* QCZ 
calpastatin ±0.13 ±0.24 ±0.22 ±0.30 ±0.09 ±0.14 ±0.10 ±0.46 ±0.17 ±0.10 ±0.03 
0.15 units 0.94""* 0.93axy 0.84"* 0.17? 1.33* 1.29 " 1.27" 1.04" 1.06* 1.15xy 1 09^ 0.80ay 115** 1.12®* 1.14"* 1.08** 
calpastatin ±0.79 ±0.09 ±0.21 ±0.06 ±0.43 0.41 ±0.37 ±0.06 ±0.47 ±0.48 ±0.23 ±0.07 ±0.40 0.23 ±0.55 ±0.62 
0.3 units 1.12' 1.14 a 0.99* 0.66 1.25 1.09ab 1.03* 1.05a 1.19 1.15 1.10* 1.14a 1.17 a 1.11" 1.10a 1.13a 
calpastatin ±0.19 ±0.25 ±0.44 ±0.65 ±0.52 ±0.55 ±0.54 ±0.04 ±0.36 ±0.51 ±0.44 ±0.42 ±0.23 ±0.27 ±0.41 ±0.47 
pH 6.5 
0 units 0.93av 1.07" 0.24* 0Z 1.13" 0.80** ' 0.45= Q44bcwXy 1.02" 0.95" 0.86" 0bz 0.85bv 0.56bw 0.47bwx 0.42bx 
calpastatin ±0.03 ±0.22 ±0.02 ±0.33 ±0.22 ±0.02 ±0.27 ±0.20 ±0.03 ±0.16 ±0.02 ±0.02 ±0.10 ±0.05 
0.15 units 0.83b 0.67* 0.48* 0.38 0.92 0.73 b 0.60 bc 0.50 0.89yz 0.79 0.78a 0.75a 0.88* 0.77a 0.73* 0.68* 
calpastatin ±0.03 ±0.26 ±0.33 ±0.38 ±0.23 ±0.12 ±0.26 ±0.38 ±0.06 ±0.18 ±0.20 ±0.29 ±0.23 ±0.21 ±0.33 ±0.37 
0.3 units 0.95aby 0.93"* 0.66= 0.40= 0.98? 0.94* 0.64bz 0.65 bz 0.88yz 0.86yc 0.81ayz 0.65ayz 0.78abyz 0.71ayz 0.63*^ 0.61abyz 
calpastatin ±0.12 ±0.14 ±0.04 ±0.33 ±0.14 ±0.10 ±0.05 ±0.17 ±0.23 ±0.15 ±0.37 0.43 ±0.33 ±0.38 ±0.38 ±0.49 
a,b
'
c Within a column, least squares means lacking a common superscript differ (P < 0.05) 
vw
'
z Within a row, least squares means lacking a common superscript differ (P < 0.05) 
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Table 9. P-values of main effects and interactions of environmental conditions on m-calpain 
degradation of desmin 
Treatment effects 2 min 15 min 60 min 120 min 
pH 0.08 0.08 0.20 0.55 
Ionic strength 0.99 0.99 0.49 0.24 
Calpastatin 0.46 0.11 0.002 0.003 
Oxidation 0.38 0.54 0.12 0.15 
pH x Ionic strength 0.32 0.37 0.55 0.41 
pH x calpastatin 0.10 0.01 0.0006 0.002 
pH x oxidation 0.19 0.21 0.047 0.09 
Ionic strength x calpastatin 0.60 0.21 0.012 0.001 
Ionic strength x oxidation 0.71 0.95 0.36 0.08 
Calpastatin x oxidation 0.72 0.36 0.005 0.005 
pH x Ionic strength x calpastatin 0.29 0.07 0.011 0.003 
pH x Ionic strength x oxidation 0.57 0.71 0.24 0.29 
pH x calpastatin x oxidation 0.32 0.11 0.002 0.001 
Ionic strength x calpastatin x oxidation 0.87 0.64 0.047 0.006 
pH x ionic strength x calpastatin x oxidation 0.76 0.48 0.05 0.006 
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FORMATION OF THE g-CALPAIN/CALPASTATIN COMPLEX ALLOWS 
ACTIVATION OF fi-CALPAIN UNDER OXIDIZING CONDITIONS 
A paper to be submitted to Biochemical Journal 
Kasey R. Maddock*, Elisabeth Huff-Lonergan, Steven M. Lonergan 
Synoposis: 
Calpains are cysteine proteinases responsible for many biological roles in muscle that 
include protein degradation and muscle growth [1], and myoblast fusion [2]. Calpains are 
inhibited by calpastatin, an endogenous inhibitor, as well as pH, ionic strength, and oxidation 
within the cell. The influence of pH and ionic strength has been well characterized, but the 
effect of oxidation on calpain activity is relatively uncharacterized. The objective of this study 
was to determine if, in the presence of calpastatin, p-calpain can be active under oxidizing 
conditions. Results from this study indicate that autolysis of ^-calpain occurred when the [i-
calpain/calpastatin complex was exposed to an oxidant or cysteine modifier such as N-
ethylmaleimide (NEM). However, when p-calpain was exposed to the cysteine modifier prior 
to calpastatin, autolysis of g-calpain did not occur. Additionally, irreversible modification of 
cysteine residues prevented activation of p-calpain in the absence of calpastatin as was 
observed with NEM, but if the cysteine modification is potentially reversible (H2O2), ^-calpain 
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activity can be recovered. Results from this study indicate that when calpastatin is bound to |_i-
calpain, activation of ^-calpain can occur when exposed to a cysteine modifier (NEM) or 
oxidizing conditions (H2O2). When domain I calpastatin or calpain inhibitor peptide 
(consisting of similar peptide sequence as subdomain B of calpastatin) was used to evaluate 
inhibition of ^-calpain by calpastatin, no effect of oxidation was observed indicating that 
calpastatin must consist of more than one inhibitory domain to be affected by NEM or H2O2. 
[x-Calpain is not tagged with maleimide-polyethyleneglycol (MAL-PEG) in the presence of 
calpastatin indicating that calpastatin prevents access of p-calpain to cysteine modification. 
Exposure of the (a-calpain/calpastatin complex with a cysteine modifier allows activation of \x-
calpain indicating that the inhibitory action of calpastatin is compromised. These results 
indicate a regulatory role for calpastatin that is not inhibitory, but protective for p-calpain. 
Keywords: ^-calpain, calpastatin, oxidation, H2O2, cysteine protease 
Introduction 
Calpains are calcium activated cysteine proteinases that require the exchange of 
electrons between the active site cysteine and histidine residues for activation [3]. ^-Calpain is 
a heterodimer with a large catalytic subunit of approximately 80 kDa and a smaller subunit of 
30 kDa. (x-Calpain is expressed in most mammalian and avian cells. The biological role for 
calpains is still under investigation and has been since the purification of m-calpain in 1976 
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[1]. It is known that calpains cleave specific sites in native proteins and produce large 
polypeptide fragments. Substrates of calpain have been placed into various categories 
including cytoskeletal proteins, kinases and phosphatases, membrane associated proteins, and 
some transcription factors [5]. This broad array of proposed substrates provides evidence that 
calpains are involved in diverse cellular process including signal transduction, apoptosis, cell 
division and cell fusion [5-8]. 
The calpain inhibitor, calpastatin, binds to the calpain heterodimer in the presence of 
calcium at three sites, domain VI on the 28-kDa subunit and domain IV on the 80-kDa subunit 
[9] and also to or near the active site of calpain [10]. One calpastatin molecule has 4 inhibitory 
domains and within each domain are three subdomains (A, B, and C). Each subdomain 
interacts with calpain; therefore it is possible that one calpastatin molecule is able to interact 
with four different calpain molecules [11-12]. Whether four interactions do occur has not yet 
been determined. 
Maddock et al. [13] demonstrated that when the p-calpain/calpastatin complex was 
exposed to oxidizing conditions, greater proteolytic activity was observed than when the 
complex was not exposed to oxidizing conditions. However, a specific mechanism is not yet 
defined. The cysteine residue in the active site of cysteine proteases is highly susceptible to 
oxidation by H2O2 [14]. Oxidation of calpain with H2O2 causes inactivation of calpain [15], 
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however if reducing conditions are introduced, g-calpain activity can be recovered. Hydrogen 
peroxide is widely produced in cells and tissues, thereby the common oxidant used when 
studying oxidation biology [16]. The main product produced between a protein and H2O2 is 
sulfenic acid. Sulfenic acid is unstable and can easily be converted back to a sulfhydryl under 
reducing conditions [16] thus explaining the irreversible effects of H2O2 on calpain activity. 
Previous research found that a) calpastatin decreased ^-calpain degradation of desmin 
and b) the presence of oxidizing conditions clearly decreased desmin degradation by |>calpain 
[13]. However, increased degradation of desmin was observed in the presence of H2O2 as 
increased amounts of calpastatin were added to the digests. Thus, it is notable that oxidation 
of the n-calpain/calpastatin complex resulted in greater desmin degradation [13]. 
These observations lead to the hypothesis that calpastatin, when interacting with (i-
calpain, may protect ^-calpain from being inactivated by oxidation. Therefore, the objective 
of this study was to determine if, in the presence of calpastatin, ^-calpain can be active under 
oxidizing conditions. 
Experimental 
Purification of calpastatin and p-calpain 
Calpastatin and p-calpain were purified from porcine skeletal muscle based on the 
procedures of Thompson and Goll [17] with minor modifications. Porcine semimembranosus 
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(~ 2-kg) was removed from a market barrow approximately 25 min after exsanguination. The 
muscle was homogenized in ice cold buffer (six volumes buffer: tissue) containing 10 mM 
EDTA, 0.1% (vol/vol) p-mercaptoethanol (MCE), and 100 mMTris-HCl, pH 8.3. Protease 
inhibitors (2.5 pMtrans-Epoxysuccunyl-L-leucylamido- [4-guanidino] butane (E-64), 0.1 
mg/mL ovomucoid trypsin inhibitor, and 0.2 mM phenylmethylsulfonylfluoride [PMSF]) were 
added to the buffer prior to homogenization. The homogenate was centrifuged at 9750 x g at 
4°C for 30 min. The supernatant was filtered through cheesecloth and proteins were salted out 
between 0 and 45% ammonium sulfate saturation. Proteins were pelleted at 9750 x g at 4°C 
for 30 min, resuspended in 1 mMEDTA, 0.1 % MCE, 40 mMTris-HCl, pH 7.4 (TEM), stirred 
overnight at 4°C, and dialyzed against TEM. The sample was loaded on a Q-Sepharose Fast 
Flow (Amersham Biosciences, Piscataway, NJ) anion-exchange column (900 mL) equilibrated 
in TEM. Using a gradient of 0 to 500 mMKCl in TEM (total volume 4,500 mL), porcine 
calpastatin and ^-calpain were eluted in two separate peaks from the column (calpastatin 
eluted between 90 and 150 mMKCl and p-calpain between 160 and 190 mMKCl). 
Purification of calpastatin 
Fractions containing calpastatin activity were pooled and further purified using 
methods described by Thompson and Goll [17] with modifications from Geesink and 
Koohmaraie [18]. The sample was heated at 100°C for 20 min, chilled on ice, and centrifuged 
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at 9750 x g at 4°C for 30 min. Using successive chromatography over Phenyl Sepharose 6 
Fast Flow (Amersham Biosciences, Piscataway, NJ), Blue Sepharose 6 Fast Flow (Amersham 
Biosciences, Piscataway, NJ), and EMD TMAE 650 S (EM Science, Gibbstown, NJ), 
calpastatin was further purified. Purified calpastatin consisted of a single 68 kDa band when 
analyzed by SDS-PAGE and had a specific activity of 365 U/mg protein. One unit of 
calpastatin activity was defined as the ability to inhibit one unit of m-calpain caseinolytic 
activity [19]. 
Purification of ju-calpain 
g-Calpain was purified according to the methods of Thompson and Goll [17 with 
minor modifications. Fractions from the Q-sepharose column containing g-calpain activity 
were pooled. (i-Calpain was further purified using successive chromatography over a Phenyl 
Sepharose 6 Fast Flow (Amersham Biosciences, Piscataway, NJ), Butyl Sepharose 4 Fast Flow 
(Amersham Biosciences, Piscataway, NJ), and EMD TMAE 650 S (EM Science, Gibbstown, 
NJ). Purified (i-calpain had a specific activity of 67 U/mg protein. One unit of calpain was 
defined as the amount of calpain required to increase the absorbance at 278 nm of the 
supernatant by one unit due to the release of trichloroacetic acid-soluble polypeptides resulting 
from the digestion of casein [20]. 
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Incubation of ju-calpain with N-ethylmaleimide 
N-ethylmaleimide (NEM) targets protein thiol groups on cysteine residues working as 
an irreversible alkylating agent [21]. Alkylation is irreversible in the presence of reducing 
conditions. Purified porcine ^-calpain (0.6 units) was incubated in 165 mM NaCl, 50 mM 
HEPES, pH 6.5, on ice for 1 h under each treatment group (n=3). Treatment groups consisted 
of 1) 100 (iM CaCl%; 2) 4 mM NEM 3) 4 mM NEM with 100 |-iM CaClz; 4) 1.2 units purified 
porcine calpastatin and 100 |_iM CaCh; and 5) 1.2 units calpastatin, 100 pM CaCb, then 4 mM 
NEM; or 6) 4 mM NEM, then 1.2 units calpastatin, 100 pM CaClz. Calpastatin was used in 
this experiment at a ratio of 2:1 calpastatin to ^-calpain. Units of calpastatin were determined 
by measurement against 0.45 units of m-calpain caseinolytic activity/ml in the assay [19. The 
excess of calpastatin was used to increase the efficiency of p-calpain interaction in the 
presence of calcium. A control of ^-calpain incubated in 50 mM HEPES; pH 6.5 on ice for 1 
h was used. After incubation, reactions were stopped with 20 mM EDTA. Samples were 
aliquoted for casein zymography and SDS-PAGE analysis. Comparisons of treatment groups 
were made on the basis of p-calpain activity and autolysis. 
Incubation of /i-calpain with H2O2 
Hydrogen peroxide is produced in many cells and tissues and reacts with protein thiols 
forming sulfenic acid [22]. Sulfenic acid is a reversible product of H2O2 oxidation. Purified 
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porcine p-calpain (0.6 units) was incubated in 50 mM HEPES, pH 6.5, on ice for 1 h at 165 
mM NaCl under each treatment group (n=3). Treatment groups consisted of 1) 100 pM CaCh; 
2) 0.170 pM H2O2 3) 0.170 pM H2O2 with 100 pM CaCh; 4) 1.2 units purified porcine 
calpastatin and 100 jxM CaCh; and 5) 1.2 units calpastatin, 100 p,M CaCl2, then 0.170 p.M 
H2O2; or 6) 0.170 f-iM H2O2, then 1.2 units calpastatin, 100 |iM CaCh. Calpastatin was used in 
this experiment at a ratio of 2:1 calpastatin to p-calpain. Units of calpastatin were determined 
by measurement against 0.45 units of m-calpain caseinolytic activity/ml in the assay [19]. The 
excess of calpastatin was used to increase the efficiency of p-calpain interaction in the 
presence of calcium. A control of p-calpain incubated in 50 mM HEPES; pH 6.5 on ice for 1 
h was used. After incubation, reactions were stopped with 20 mM EDTA. Samples were 
aliquoted for casein zymography and SDS-PAGE analysis. 
Ionic strength comparisons 
Purified porcine p-calpain (0.6 units) was incubated in 50 mM HEPES, pH 6.5, on ice 
for 1 h at 165 mM NaCl or 295 mM NaCl. Previous experiments [23] indicate the ionic 
strength affects g-calpain activity and inhibition by calpastatin. Treatment groups consisted of 
1) 100 pM CaCh; 2) 0.170 pM H2O2 3) 0.170 |iM H202 with 100 pM CaCl2; 4) 1.2 units 
purified porcine calpastatin and 100 |xM CaCh; and 5) 1.2 units calpastatin, 100 |o.M CaCh, 
then 0.170 pM H2O2; or 6) 0.170 pM H2O2, then 1.2 units calpastatin, 100 pM CaCh. A 
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control of ji-calpain incubated in 50 mM HEPES; pH 6.5 on ice for 1 h was used. After 
incubation, reactions were stopped with 20 mM EDTA. Samples were aliquoted for SOS-
PAGE analysis. 
Incubation of ju-calpain with calpastatin, domain I of calpastatin, and a calpain inhibitor 
peptide 
Purified porcine p-calpain (0.6 units) was incubated in 50 mM HEPES, pH 6.5, on ice 
for 1 h at 165 mM NaCl. Three different forms of calpastatin were used to compare effects of 
H2O2. The calpastatin forms consisted of the purified calpastatin from porcine 
semimembranosus, as described above, the second was highly purified domain I of human 
calpastatin (14 kDa; Takara Bio Inc., Otsu, Shiga, Japan), and the third was a calpain inhibitor 
consisting of the 26 amino acids DPMSSTYIEELGKREVTIPPKYRELL (Takara Bio Inc., 
Otsu, Shiga, Japan) based on the amino acid sequence of subdomain B in human calpastatin. 
Activity of all three calpain inhibitors were standardized based on inhibitory activity against p-
calpain where one unit of calpastatin activity was defined as the ability to inhibit one unit of p-
calpain caseinolytic activity [19]. Treatment groups consisted of 1)1 mM CaCh; 2) either 
1.14 units porcine calpastatin, domain I calpastatin, or calpain inhibitor, all treatments 
contained 1 mM CaCh. Oxidation treatments consisted of 3) 1.14 units porcine calpastatin, 
domain I calpastatin, or calpain inhibitor, ImM CaCh was added, and finally 0.170 pM H2O2; 
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or 4) 0.170 pM H2O2, 1.14 units porcine calpastatin, domain I calpastatin, or calpain inhibitor, 
1 mM CaCh. A p-calpain control incubated in 50 mM HEPES; pH 6.5 on ice for 1 h was used. 
After incubation, reactions were stopped with 20 mM EDTA. Samples were aliquoted for 
casein zymography and SDS-PAGE analysis. Comparisons were made between treatment 
groups on p-calpain activity and autolysis. 
Casein zymography and native gels 
Casein zymography [24] was used to determine remaining p-calpain activity after 
incubation. Native gels were used to confirm p-calpain was present in the sample. Gel 
samples were made for casein zymography and nondenaturing polyacrylamide gels by diluting 
the sample 70:30 (sample: electrophoresis sample buffer [20% glycerol, 0.1% bromphenol 
blue, 0.75% 2-mercaptoethanol (MCE), 150 mM Tris-HCl, pH 6.8]. Samples were loaded 
onto nondenaturing acrylamide gels containing casein and identical nondenaturing gels that 
did not contain casein. Gels were run at a constant voltage of 75 V for approximately 18 
hours. Casein gels were incubated in 5 mM CaCh, 0.1 % MCE, 50 mM Tris-HCl, pH 7.5 
solution overnight at room temperature to active any potentially active p-calpain. Both casein 
and native gels were stained in 0.1 % Coomassie brilliant-blue R-250,40% methanol, and 7% 
acetic acid solution and then destained in a 40% methanol, 7% acetic acid solution. Clear 
zones on the casein zymograms indicated activation of p-calpain. Stained protein on the 
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native gels confirmed the presence of p-calpain in the gel sample that was used in the casein 
zymograms when no active p-calpain was detected. Images were taken using a 16-bit 
megapixel CCD camera FluorChem880 (Alpha Innotech Corp., San Leandro, CA) and 
FluorChem IS800 software (Alpha Innotech Corp.) 
SDS-PAGE 
Gel samples were prepared for SDS-PAGE [25] by diluting samples 70:30 (sample: 
buffer tracking dye solution [3 mM EDTA, 3% SDS, 20% glycerol, 0.003% pyronin Y, and 30 
mM Tris-HCl, pH 8.0]. Samples were run on a 10% polyacrylamide separating gel at a 
constant voltage of 120 V for approximately 3.5 hours. Gels were stained in 0.1% Coomassie 
brilliant blue R-250,40% methanol, and 7% acetic acid solution, and destained in a 40% 
methanol, 7% acetic acid solution. Differences in autolysis of the 80 kDa subunit of (x-calpain 
to a 78-kD and a 76-kDa autolysis product were evaluated. Images were taken using a 16-bit 
megapixel CCD camera FluorChem880 (Alpha Innotech Corp.) and FluorChem IS800 
software (Alpha Innotech Corp.) 
Incubation of /j-calpain with MAL-PEG 
Purified porcine p-calpain (0.4 units) was incubated in 165 mM NaCl, 50 mM HEPES, 
pH 6.5. Treatment groups consisted of 1)1 mM CaCh; 2) 0.170 |iM H2O2 3) 0.8 units 
purified porcine calpastatin and 1 mM CaCh. Units of calpastatin were determined by 
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measurement against 0.45 units of m-calpain caseinolytic activity/ml in the assay [19]. 
Samples were treated with NEM and MAL-PEG according methods of Makmura et al. [26]. 
Duplicates of each treatment were treated with 20 mM NEM; all samples were incubated on 
ice for 1 hour. Samples were dialyzed in 50 mM HEPES, pH 6.5 at 4°C for approximately 2 
hours (> 1000 x vol) to remove excess NEM. Maleimide-polyethyleneglycol (MAL-PEG; 4 
mM final conc.; MW=5000) was added to each treatment and incubated for 1 h on ice. 
Controls of p-calpain and p-calpain and MAL-PEG were incubated in 50 mM HEPES; pH 6.5 
on ice for 1 h was used. Samples were aliquoted for SDS-PAGE and western blot analysis. 
SDS-PAGE and membrane transfer were conducted as described by Rowe et al. [27] using 9% 
polyacrylamide separating gels and a p-calpain primary antibody (monoclonal anti p-calpain 
antibody, M A3-940; Affinity Bioreagents, Inc., Golden, CO) for p-calpain diluted 1:40000 
and a secondary antibody (goat anti-mouse conjugated with horseradish peroxidase, catalog 
no. A2554; Sigma Chemical Company) diluted 1:10000. A sensitive chemiluminescent (ECL 
Plus kit; Amersham Biosciences, Piscataway, NJ) system was used to detect labeled protein 
bands using a charged coupled device (CCD) camera (FluroChem 8800; Alpha Innotech 
Corporation, San Leandro, CA) and FluorChem IS-800 software (Alpha Innotech Corporation, 
San Leandro, CA). Comparisons were made between treatment groups on molecular weight 
shifts of p-calpain. 
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Results and Discussion 
Previous research [13], using purified porcine myofibrils as a substrate, determined that 
p-calpain proteolytic activity was inhibited by calpastatin and oxidation as determined by 
degradation of desmin. Calpastatin inhibited p-calpain activity in the samples that had not 
been exposed to H2O2, as shown by an increase in intact desmin. Oxidation with H2O2 clearly 
inhibited desmin degradation by p-calpain, particularly when no calpastatin was used in the 
experiment. However, inclusion of H2O2 with p-calpain and calpastatin at pH 6.5 and 7.5 
proved to stimulate proteolysis of desmin, indicating increased p-calpain activity. This lead to 
the hypothesis that calpastatin, when bound to p-calpain, can at least partially prevent p-
calpain from being oxidized. 
In the NEM treated calpain (Figure 1, Lane 2), the lack of clear zones in casein 
zymograms indicated that p-calpain was no longer active, which corresponds to results of 
Inomata and Kawashima [28], where NEM was used as a calpain inactivator. In the H2O2 
treated samples (Figure 2, Lane 7), clear zones on the casein zymograms indicate that active p-
calpain was present in the samples, which demonstrates that p-calpain in the experiments was 
not irreversibly inactivated, either by autolysis or oxidation. The use of the two different 
reagents to alter cysteine residues determined if the inhibition of calpain activity occurred and 
if the inhibition was reversible. The stained native gels (Figures 1A and 2 A) correspond to the 
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casein gels and indicate the presence of p-calpain in gel samples loaded onto the casein 
zymograms. SDS-PAGE gels (Figures 1A and 2A) indicate activation of p-calpain based on 
autolysis of the large 80 kDa subunit degrading to a 78 kDa and 76 kDa subunit. Autolysis is 
often used as an indicator of p-calpain activation and can also directly cause inactivation of p-
calpain [29] as shown in Figure 2A (Lane 10). Incubation of p-calpain with NEM resulted in 
loss of p-calpain proteolytic activity (Figure 1A [Lane 2] and IB). NEM binds irreversibly to 
reduced cysteine residues on proteins [30], acting as an alkylating agent. Therefore NEM may 
bind the active site cysteine residue or possibly to one of the other 10 cysteine residues on p-
calpain, irreversibly preventing activation. When NEM was incubated with p-calpain in the 
presence of calcium, autolysis of p-calpain did not occur (Figure 1A [Lane 2] and IB), 
indicating that p-calpain was not activated and did not become active in the casein 
zymograms. 
Predictably, calpastatin inhibited p-calpain autolysis. p-Calpain activity was observed 
on casein zymograms (Figure 1A [Lanes 5, 7, 9], IB, and Figure 2A [Lane 1], 2B) after 
incubation with calpastatin and calcium, and autolysis occurred at a much slower rate than p-
calpain incubated with calcium alone. When NEM was added after the formation of the p-
calpain/calpastatin complex (Figure 1A [Lanes 6, 8,10] IB and Figure 2A [Lane 3]), autolysis 
of p-calpain did occur to a greater extent compared to when only calpastatin and calcium were 
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present. Therefore, calpastatin alone inhibited p-calpain autolysis, but the addition of NEM to 
the reaction after the formation of the p-calpain/calpastatin complex caused autolysis to occur 
to a greater extent and autolytic inactivation of p-calpain did occur. This is an interesting 
observation in that NEM alone caused complete loss of p-calpain activity and prevented 
autolysis, calpastatin prevented autolysis, but after formation of the p-calpain/calpastatin 
complex, incubation with NEM created conditions that promoted autolysis of p-calpain to 
occur. In Maddock et al. [13], calpastatin was incubated with NEM (0,4, 8, or 12 mM final 
concentration) to determine the effect of a cysteine modifier on calpastatin activity. Specific 
activity of calpastatin was not changed by exposure to NEM. Therefore calpastatin, if not in 
formation with calpain, is not affected by exposure to an irreversible cysteine modifier [13]. 
Incubation of p-calpain with H2O2 resulted in no irreversible loss of proteolytic activity 
as shown in casein zymograms after reduction of samples (Figure 2A [Lane 7] and 2B), which 
is in contrast with the NEM incubations, where proteolytic activity was not observed in the 
casein zymograms. Oxidation with H2O2 is reversible when exposed to a reducing agent, as 
was done in the casein zymogram samples. When calcium was used in the incubation of p-
calpain with H2O2, autolysis did occur (Figure 2 [Lane 2] and 2B) which is similar to results 
observed by Guttmann et al. [16] and autolytic inactivation of p-calpain activity was observed. 
Addition of H2O2 after formation of the p-calpain/calapstatin complex resulted in p-calpain 
autolysis (Figure 2 [Lanes 5 and 9] and 2B). The result is consistent with the result when 
NEM is added to the p-calpain/calpastatin complex. Conversely, when H2O2 was added to p-
calpain before the addition of calpastatin and calcium (Figure 2 [Lanes 6 and 8] and 2B), no 
autolysis of p-calpain was observed and proteolytic activity was still apparent on the casein 
zymograms, which in combination indicated that p-calpain had not been irreversibly 
inactivated. Collectively, the results indicated that oxidation of the p-calpain/calpastatin 
complex promotes autolysis, activation, and subsequent autolytic inactivation of p-calpain. 
This conclusion is consistent with the results discussed in Maddock et al. [13] that indicated 
greater proteolytic activity and autolysis of p-calpain occurred in the presence of calpastatin 
and H2O2. Conversely, exposure of p-calpain to a cysteine modifier (NEM or H2O2) before 
exposure to calpastatin inhibits autolysis of calpain. Interestingly, the reagents used in the 
study appeared to affect the p-calpain/calpastatin complex similarly, but when used alone, 
NEM causes complete and irreversible loss of proteolytic activity, whereas H2O2 inactivation 
of p-calpain is reversible and proteolytic activity is recovered if reducing conditions are 
introduced. The reversibility of H2O2 oxidation indicates that the oxidation that occurred was 
probably conversion of a cysteine thiol to sulfenic acid [16]. Sulfenic acid is a product of 
H2O2 oxidation that is easily reduced back to a sulfhydryl group if proper reducing conditions 
are introduced. 
Oxidation has been shown to decrease activity of calpains, but in contrast, calpains 
have also been shown to play a role in protein degradation in vivo when oxidative conditions 
are higher than normal. A relationship between protein oxidation and proteolysis has been 
clearly established [31] where oxidation of proteins can enhance susceptibility to proteolytic 
degradation, but at the same time, excessive oxidation may cause a decrease in susceptibility to 
degradation. The increase in susceptibility has been discussed in regard to the proteosome 
system, which has a preference to bind hydrophobic residues [32]. Oxidation of proteins 
causes an exposure of hydrophobic residues [33] increasing its susceptibility to the proteosome 
system. It is hypothesized that the proteosome is necessary in the removal of oxidatively 
modified or damaged proteins [31]. So far, no studies exist showing direct recognition of 
oxidized substrates causing increased susceptibility to calpain [31]. However, oxidative stress, 
in combination with observed increased intracellular Ca2+ concentration in a mouse embryonal 
carcinoma cell line [34] and a rat adrenal gland cell line [35] have shown an increase in 
activation of calpains in general. The activation of calpains in these instances is possibly 
linked to the increase in intracellular calcium, rather than an increase in the susceptibility of 
the calpain substrates to degradation. However, Pronzato et al. [36] observed the level of 
oxidative stress can affect calpain activity, where moderate levels of oxidation enhance 
activity but increased oxidative exposure can cause inactivation of calpains. Based on the 
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results of Saurin et al. [16], moderate levels of oxidation is defined as a high enough 
concentration of H2O2 to affect protein activity through formation of sulfenic acid, which is a 
reversible modification. Higher concentrations or increased exposure of H2O2 to proteins 
allows for production of sulfinic acid and sulfonic acid [16]. The formation of these acids is 
irreversible, thus irrevocably changing protein functionality. These observations could 
provide an explanation of how the involvement of calpastatin regulates oxidation of p-calpain 
and allows activation to occur. 
Previous research has evaluated the effect of ionic strength on p-calpain activity [22] 
where it was determined that higher ionic strength decreased p-calpain activity. A comparison 
of treatments at two different ionic strengths, 165 mM NaCl and 295 mM NaCl, is shown in 
Figure 3. Results indicate that the higher ionic strength slowed autolysis of p-calpain in the 
presence of H2O2 and calcium (Figure 3, Lanes 5A and 5B). The higher ionic strength also 
caused greater autolysis to occur in the presence of calpastatin (Figure 3, Lanes 3A and 3B). 
Geesink and Koohmaraie [37] indicated that a decrease in activity of p-calpain at higher ionic 
strengths is the result of a decrease in the stability of the molecule. Li et al. [38] hypothesized 
a higher ionic strength causes dissociation of the heterodimeric subunits of p-calpain, which 
allow for formation of dimers and timers of the large subunit, subsequently inactivating the 
proteinase. These results indicate that differences in ionic strength have the potential to affect 
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activity of p-calpain through autolytic inactivation and dissociation. Differences in ionic 
strength did not have any apparent effects on the effects of oxidation on p-calpain and 
calpastatin. 
To more closely evaluate the role of calpastatin in the activation of p-calpain in the 
presence of H2O2, three different calpastatins were evaluated (Figure 4). The first is the 
purified porcine calpastatin used in the previous experiments, the second is an expressed 
peptide fragment from domain I of human calpastatin, and the third is synthetic peptide 
consisting of 26 amino acids that replicate the homologous sequence of amino acids found in 
subdomain B of the inhibitory calpastatin domains. Uemori et al. [39] determined that 
subdomain B is essential for inhibitory activity of calpastatin to occur. A similar peptide to the 
one in this study was determined to bind to a highly conserved region of domain III of p-
calpain [40] indicating that this peptide does not block to active site where the cysteine residue 
is located. The three forms of calpastatin were used on an equal activity basis, which was 
determined using a casein assay [20] against p-calpain. Calpastatin was added to the 
incubations at twice the amount of p-calpain activity to maximize calpastatin interaction with 
p-calpain. Autolysis was observed (Figure 4, Lanes 2, 12) when p-calpain was incubated with 
porcine calpastatin, whereas domain I calpastatin (Figure 4, Lane 4) completely inhibited 
autolysis of p-calpain. Autolysis stopped at the 78 kDa band (Figure 4, Lane 14) when p-
calpain was incubated with the calpastatin peptide 26mer. When these calpastatins were tested 
similarly to the previously described experiment with H2O2 added after the calpastatin in order 
to allow formation of the p-calpain/calpastatin complex (Figure 4, Lanes 5 and 15), autolysis 
of porcine p-calpain occurred and p-calpain activity was decreased. When H2O2 was added 
before calpastatin (Figure 4, Lanes 8 and 18), autolysis of p-calpain did occur but was slower 
than when H2O2 was added after the calpastatin. However, no differences were observed due 
to order of H2O2 addition in p-calpain autolysis or activity when the domain I (Figure 4, Lanes 
6,9,16,19) or calpastatin peptide (Figure 4, Lanes 7,10,17, and 20) were used regardless of 
when or if H2O2 was added to the assay. This is consistent with the results described by Croall 
and McGrody [40] where the peptide used in their study does not bind at the active site and the 
results described by Guttmann et al.[15], where H2O2 did not inhibit autolysis and proteolytic 
activity is recoverable. To summarize, the porcine calpastatin prevented autolysis, but 
complete autolysis did occur if H2O2 was added, the domain I calpastatin prevented any 
autolysis from occurring, even when exposed to H2O2, and the peptide fragment permitted 
autolysis to occur to only the 78 kDa band regardless of H2O2 treatment. The differences 
observed in the different calpastatin molecules could be due to the interaction of calpastatin 
with p-calpain at sites other than the subdomain B inhibitory region. Subdomains A and C in 
the calpastatin molecule were not present in the peptide fragment. The lack of these 
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subdomains could explain why autolysis occurred when the peptide fragment was used. The 
roles of subdomains A and C in calpain inhibition have been attributed to stabilizing the 
calpain molecule by binding to domains IV and VI [9] and increasing calpain inhibition [41]. 
However, the peptide fragment only allowed autolysis of p-calpain to the 78 kDa form. 
Melloni et al. [42] determined that calpastatin was a better inhibitor of autolysis of p-calpain 
from the 78 kDa to the 76 kDa form. The differences observed with the purified porcine 
calpastatin and domain 1 calpastatin may be contributed to the fact that the purified porcine 
calpastatin is a larger molecule, which may affect how H2O2 interacts with p-calpain when 
compared to the smaller domain I calpastatin. The larger molecule may physically prevent 
oxidation of another cysteine residue that is required to be reduced for activation in 
comparisons to smaller domain I of calpastatin. The larger calpastatin molecule may also be a 
target for NEM and H2O2 when bound to p-calpain, thus altering their interaction, thereby 
decreasing the inhibition of p-calpain. 
The use of MAL-PEG is to evaluate tagging of reduced cysteine residues as indicated 
by a molecular weight shift when run on SDS-PAGE. Maleimides covalently bind to free 
sulfhydryl groups on proteins [26], and have the highest affinity for cysteine residues. Results 
indicate the MAL-PEG will tag p-calpain with or without the presence of calcium (Figure 5, 
Lanes 2 and 3). Additionally, p-calpain oxidized with H2O2 was also tagged with MAL-PEG, 
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indicating that not all cysteine residues are altered by H2O2. It has been determined that H2O2 
does inhibit p-calpain activity, but it does not inhibit autolysis (Figure 2, Lane 2), which 
corresponds to Guttmann et al. [15]. Therefore, it is likely that cysteine residues other than the 
active site cysteine are the targets of oxidation, and may affect proteolytic function of p-
calpain by altering its ability to target its substrates or interaction to calpastatin, but not 
preventing activation, which allows for autolysis to occur. Calpastatin prevented MAL-PEG 
from tagging p-calpain (Figure 5, Lane 5) indicating that calpastatin blocks or essentially 
"protects" p-calpain from being targeted by cysteine modifiers NEM or MAL-PEG. 
Oxidative processes of living cells are balanced with the antioxidant systems in cells, 
but the oxidative processes can cause production of reactive oxygen species. These ROS will 
react with lipids and proteins found in the tissues. Specifically, oxidation of proteins can alter 
function, but prevention or regulation of oxidation of proteins like calpain can regulate calpain 
activity. Results from this study indicate that calpastatin may play a role in the regulation of 
calpain oxidation. Calpastatin prevents cysteine modification of p-calpain, thus preventing 
inactivation of p-calpain. Additionally, exposure of the p-calpain/calpastatin complex to a 
cysteine modifier decreases the inhibition of p-calpain by calapstatin, indicating that 
calpastatin, when bound to p-calpain may also be a target of NEM and H2O2. Further research 
must be conducted to elucidate the mechanism of the interaction of p-calpain with calpastatin, 
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and additionally, the importance of a reducing environment on calpain activation needs to be 
clarified as cysteine residues other than the active site cysteine may be involved. The data 
from this study indicate that irreversible modification of a p-calpain cysteine residue prevents 
p-calpain activation and autolysis. Additionally calpastatin, in an intact form containing more 
than one inhibitory domain, allows for activation of p-calpain when exposed to a cysteine 
modifier. Calpastatin, therefore, may regulate calpain activity related to pathological 
conditions where oxidative stress is prevalent such as ischemia, cataract formation, and 
Alzheimer's disease. 
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Figure 1. p-calpain incubations with NEM at pH 6.5 (n-3). 
1 2 3 4 5 6 7  8 9  1 0  
Casein 
zymogram1 
Native gel 
SDS-PAGE" 
76 kDa 
Calpastatin 
Treatment (Lane on gels) 
Proteolytic 
activity Autolysis 
C) p-calpain (1) b +++ 
1) p-calpain + CaCI2 (3) +++ +++ 
2) |j-calpain + NEM (2) — 
3) p-calpain + NEM + CaCh (4) — 
4) p-calpain + calpastatin + CaCh (5,7,9) ++ Hb 
5) p-calpain + calpastatin + CaCh + NEM (6,8,10) + ++ 
a b c  P r o t e o l y t i c  a c t i v i t y  o f  j i - c a l p a i n  i s  d e p i c t e d  b y  c a s e i n  z y m o g r a m  
and autolysis of n-calpain is depicted by SDS-PAGE gel. Native gel is used to 
show location of protein on casein zymograms. 
Casein 
zymogram8 
Native gelb 
80 kDa 
78 kDa SDS-PAGE' 
76 kDa 
Treatment (Lane on gels) 
Proteolytic 
activity Autolysis 
C) p-calpain (4) +++ — 
1) p-calpain + CaCI2 (10) - +-f+ 
2) p-calpain + H202 (7) +++ ---
3) p-calpain + H202 + CaCI2 (2) ++ +++ 
4) p-calpain + calpastatin + CaCI2 (1) + + 
5) p-calpain + calpastatin + CaCI2 + NEM (3) — ++ 
5) p-calpain + calpastatin + CaCI2 + H202 (5, 9) +- +++ 
6) p-calpain + H202 + calpastatin + CaCI2 (6, 8) ++ -
a,bi c Proteolytic activity of ^-calpain is depicted by casein zymogram 
and autolysis of |i-calpain is depicted by SDS-PAGE gel. Native gel is used to 
show location of protein on casein zymograms. 
Figure 2. p-calpain incubations with H2O2 at pH 6.5 (n=3) 
1 2 3 4  5 6 7 8 9  1 0  
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Figure 3. SDS-PAGE of n-calpain incubations at A) 165 mM NaCl and B) 295 mM NaCl. 
1 2 3 4 5 6 7  8 9  1 0  
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Figure 4. Casein zymograms and SDS-PAGE of p.-calpain incubations with three forms of 
calpastatin at pH 6.5. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
SOkDi 
4 78 kD 
76 kDi 
B Proteolytic 
Treatment (Lane on gels) activity Autolysis 
C) |j-calpain (1,11) +++ — 
1) |j-calpain + CaCI2 (2, 12) -/si. + +++ 
2) p-calpain + calpastatin + CaCI2(3,13) +/- ++ 
3) p-calpain + domain I + CaCI2 (4) +++ 
4) p-calpain + calpain inhibitor peptide + CaCI2 (14) +++ + to 78 
5) p-calpain + calpastatin + CaCI2 + H202 (5,15) + +++ 
6) p-calpain + H202 + calpastatin + CaCI2 (8, 18) +/- +-
7) p-calpain domain I + CaCI2 + H202 (6, 16) ++ — 
8) p-calpain + H202 + domain I + CaCI2 (9,19) + — 
9) p-calpain + calpain inhibitor peptide + CaCI2 + H202 (7,17) ++ + to 78 
10) p-calpain + H202 + calpain inhibitor peptide + CaCI2 (10, 
20) -/+ + to 78 
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Figure 5 Western blot of ^-calpain tagged with MAL-PEG. 
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GENERAL SUMMARY 
The intracellular environment of postmortem muscle changes dramatically in the first 
24 hours due to loss of homeostasis. These cellular environmental changes include a pH 
decline from near neutral to approximately 5.6, an increase in ionic strength from an 
equivalent of 165 mM NaCl to approximately 295 mM NaCl and an increase in lipid and 
protein oxidation. Previous studies have determined the extent to which effects of pH, ionic 
strength, and oxidation influence calpain activity. Many of these studies have included the 
effects of calpastatin on calpain under these varying environments. The majority of these 
studies only evaluated one or two environmental conditions, but as more is understood about 
the calpain system, the interactions of these environments can impact calpain activity in a 
much different way. 
Our (i-and m-calpain activity assays using a fluorescent peptide as a substrate 
demonstrate that there are differences in activation of p-calpain and m-calpain and their 
inhibition by calpastatin. p-Calpain activity was greatest at pH 6.5 and m-calpain activity was 
greatest at pH 7.5, and m-calpain activity was not detected at pH 6.0. Inhibition of p-calpain 
by calpastatin was higher (P < 0.01) in 295 mM NaCl than 165 mM NaCl when 0.3 units of 
calpastatin were included in the assay. Inhibition of m-calpain was greater (P < 0.01) when 
calpastatin was added at pH 6.5 than 7.5 at 165 mM NaCl, whereas percent inhibition of m-
calpain was greater (P < 0.01) at 295 mM than 165 mM NaCl at pH 7.5 and 6.5. The effects of 
pH and ionic strength on calpain activity and calpain inhibition by calpastatin support the 
hypothesis that p-calpain and not m-calpain is most likely to be active in postmortem muscle. 
Oxidation decreased activity of both p- and m-calpain, but oxidation decreased inhibition of p-
and m-calpain by calpastatin indicating that H2O2 was either not affecting calpain in the 
presence of calpastatin, or H2O2 was directly affecting calpastatin inhibition of calpains. 
When the same conditions of pH, ionic strength, and oxidation on p- and m-calpain activity in 
the presence of calpastatin were evaluated in degradation of desmin, similar effects of 
oxidation in the presence of calpastatin were observed for p-calpain at pH 7.5 and 6.5. 
Oxidation decreased proteolytic activity of p-calpain against desmin at pH 6.0 (P < 0.05 at 15, 
60, and 120 min) and m-calpain at all pH conditions. However, inhibition of p-calpain 
degradation of desmin by calpastatin was decreased by oxidation at pH 7.5 and 6.5 at both 
ionic strengths (P =0.03). The results suggest that, at the higher pH conditions used (pH 7.5 
and 6.5), calpastatin may limit the possibility of oxidation-induced inactivation of p-calpain. 
The results from these first experiments described in Chapter 2 and Chapter 3 lead to 
the hypothesis of the third paper that calpastatin was protecting p-calpain from H2O2 oxidation 
of the active site cysteine residue, thereby allowing p-calpain to become active. Experiments 
were summarized in Chapter 4 used cysteine modifiers N-ethylmaleimide and H2O2 on p-
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calpain at pH 6.5. In evaluation of activity and autolysis of p-calpain, calpastatin was either 
incubated with p-calpain before or after NEM or H2O2. Results indicated that the cysteine 
modifiers will inhibit p-calpain activity completely. NEM inhibition of p-calpain activity is 
irreversible, while H2O2 inhibition was reversible. If calpastatin was present before the 
addition of the cysteine modifiers, activation of p-calpain occurred. Maleimide tagged with 
polyethyleneglycol (MAL-PEG) was used in the incubations with p-calpain in order to 
determine if there is an available cysteine residue for tagging that causes a molecular weight 
shift in a SDS-PAGE. Calpastatin prevented tagging of p-calpain with MAL-PEG indicating 
that calpastatin is essentially protecting a p-calpain cysteine residue from being altered and 
thus preventing p-calpain inactivation. When two alternate forms of calpastatin were used to 
evaluate differences due to H2O2, the calpastatin containing only domain I did prevent 
autolysis regardless of the oxidative conditions, and the calpastatin peptide fragment 
containing subdomain B allowed autolysis to occur to the 78 kDa fragment of p-calpain 
regardless of the oxidative conditions, but complete autolysis of p-calpain was not observed. 
The purified porcine calpastatin used in this experiment and all previous experiments is a 
much larger molecule than the two alternative calpastatins used. The MAL-PEG experiment 
determined that the larger form calpastatin blocks p-calpain cysteine modification, however, 
calpastatin did not prevent p-calpain activity when incubated with NEM or H2O2, indicating 
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that calpastatin is probably affected by these cysteine modifiers when in a complex with p-
calpain. 
These studies show that cellular environment have a large effect on p-calpain activity. 
Conditions used in these experiments are relevant in both living and postmortem muscle. The 
differences evaluated due to interactions of pH, ionic strength, and oxidation on p-calpain 
activity in the presence of calpastatin provide a basis for understanding mechanisms 
controlling p-calpain activity in not only postmortem muscle, but the action of p-calpain in 
living cells. The role of calpastatin in p-calpain activity appears to be more regulatory rather 
than inhibitory under oxidizing conditions. Calpastatin prevented targeting of p-calpain 
cysteine residues and allowed p-calpain activity under oxidizing conditions of NEM or H2O2. 
The regulatory role of calpastatin on calpain activity starts to explain calpain action in 
conditions where oxidation is a factor such as ischemia, cataract formation, and Alzheimer's 
disease. 
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